Document:

EX-4.5

 Exhibit 4.5 

AVEANNA HEALTHCARE HOLDINGS INC. 

AMENDED AND RESTATED STOCKHOLDERS AGREEMENT 

THIS AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”) is made as of [ ], 2021 (the “Effective
Date”), by and among (i) Aveanna Healthcare Holdings Inc., a Delaware corporation (the “Company”), (ii) each of the Sponsors listed on the Schedule of Sponsors attached hereto, as such schedule may be
updated from time to time in accordance with the terms of this Agreement, (iii) each of the executives listed on the Schedule of Executives attached hereto, as such schedule may be updated from time to time in accordance with the terms
of this Agreement (the “Executives”) and (iv) each Person listed on the Schedule of Other Investors attached hereto, as such schedule may be updated from time to time in accordance with the terms of this Agreement
(collectively, the “Other Investors”). The Sponsors, the Executives and the Other Investors are collectively referred to as the “Stockholders” and each individually as a “Stockholder.” Except as
otherwise specified herein, all capitalized terms used herein are defined in Section 1. 
 WHEREAS, certain of the
parties hereto previously entered into that certain Stockholders Agreement, dated March 16, 2017 (as amended pursuant to that certain First Amendment to Stockholders Agreement, dated April 18, 2018, the “Original
Agreement”) in order to, among other things, establish the composition of the Board and to provide for certain rights and obligations of the stockholders of the Company; 

WHEREAS, simultaneously with the execution of this agreement, the Company has conducted an underwritten IPO (as defined herein) of shares of
Common Stock (as defined herein); 
 WHEREAS, in accordance with and pursuant to Section 18(b) of the Original Agreement, the Company
and the Sponsors desire to amend and restate the Original Agreement in its entirety to, among other things, provide for certain governance rights and other matters contemporaneously with the consummation of the IPO. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: 
 Section 1. Definitions.
Unless otherwise defined elsewhere in this Agreement, capitalized terms contained herein have the meanings set forth below. 

“Acquired Shares” has the meaning set forth in Section 7. 

“Affiliate” of any Person means any other Person controlled by, controlling or under common control with such Person;
provided that the Company and its subsidiaries shall not be deemed to be Affiliates of any Stockholder. As used in this definition, “control” (including, with its correlative meanings, “controlling,” “controlled
by” and “under common control with”) shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities, by contract or otherwise). With respect
to any Person who is an individual, “Affiliates” shall also include, without limitation, any member of such individual’s Family Group. 

“Agreement” has the meaning set forth in the preamble. 

“Bain Directors” has the meaning set forth in Section 2(a)(ii)(A). 

  
 1 

 “Bain Employee Director” has the meaning set forth in
Section 2(a)(ii)(A). 
 “Bain Independent Director” has the meaning set forth in
Section 2(a)(ii)(A). 
 “Bain Sponsors” means Bain Capital Fund XI, L.P., BCIP Associates IV
(US), L.P., BCIP Associates IV-B (US), L.P., BCIP T Associates IV (US), L.P., BCIP T Associates IV-B (US), L.P., Randolph Street Investment Partners, L.P. – 2016
DIF, Squam Lake Investors XI, L.P., Bain & Company, Inc., Wayne DeVeydt and each of their Permitted Transferees that acquires Stockholder Shares and becomes a Stockholder hereunder and each of their Affiliates that acquires Stockholder
Shares and becomes a Sponsor hereunder in accordance with the terms hereof. Unless otherwise agreed by the holder(s) of a majority of the Stockholder Shares collectively held by the Bain Sponsors, any consent, approval, election or action taken or
contemplated to be taken by the Bain Sponsors pursuant to this Agreement shall be taken by the holder(s) of a majority of the Stockholder Shares collectively held by the Bain Sponsors at such time. 

“Bain XI VCOC” has the meaning set forth in Section 2(a)(ii)(A). 

“Bain XI VCOC Director” has the meaning set forth in Section 2(a)(ii)(A). 

“Board” has the meaning set forth in the recitals to this Agreement. 

“Business Day” means any day that is not a Saturday or Sunday or a legal holiday in the state in which the Company’s
chief executive office is located or in New York, New York. 
 “Capital Stock” means (i) with respect to any Person
that is a corporation, any and all shares, interests or equivalents in capital stock of such corporation (whether voting or nonvoting and whether common or preferred) and (ii) with respect to any Person that is not a corporation, individual or
governmental entity, any and all partnership, membership, limited liability company or other equity interests of such Person that confer on the holder thereof the right to receive a share of the profits and losses of, and/or the distribution of
assets of, the issuing Person, including in each case any and all warrants, rights or options to purchase any of the foregoing. 

“CEO Director” has the meaning set forth in Section 2(a)(ii)(C). 

“Certificate of Incorporation” means that certain Second Amended and Restated Certificate of Incorporation of the Company,
dated as of the April 19, 2021, as amended from time to time in accordance with its terms and the terms of this Agreement. 

“Common Stock” means the Company’s Common Stock, par value $0.01 per share. 

“Company” has the meaning set forth in the preamble to this Agreement. 

“Company Capital Stock” means the Company’s Capital Stock. 

“Company Repurchase” means the repurchase of shares of Company Capital Stock by the Company from any officer, director,
employee, consultant or other service provider of the Company and/or its subsidiaries upon the termination of employment or service or other event pursuant to the terms of any approved equity incentive plan or any grant agreement thereunder. 

“Competitor” means any Person that the Board in good faith determines is a competitor; provided that a financial
sponsor who does not have a portfolio company involved in the same or similar business to the Company shall not be a competitor. 

  
 2 

 “Confidential Information” means confidential and proprietary information
and trade secrets of the Company and its subsidiaries; provided, however, that the term “Confidential Information” does not include information that (i) is already in a Person’s possession, provided that such
information is not subject to another confidentiality agreement with or other obligation of secrecy to any Person, (ii) is or becomes generally available to the public other than as a result of a disclosure, directly or indirectly, by a party
or a party’s representatives in violation of this Agreement or another confidentiality agreement with or obligation of secrecy to any Person or (iii) is or become available to a party on a
non-confidential basis from a source other than any of the parties hereto or any of their respective representatives; provided, that such source is not known by such party to be bound by a
confidentiality agreement with or other obligation of secrecy to any Person. 
 “Coordination Committee” has the meaning
set forth in Section 8. 
 “Coordination Period” shall mean the first 2 years following the consummation of the IPO.

 “Credit Facilities” means (i) that certain First Lien Credit Agreement, dated as of March 16, 2017 (as
amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among Aveanna Healthcare Intermediate Holdings LLC (f/k/a BCPE Eagle Intermediate Holdings, LLC), a Delaware
limited liability company, Aveanna Healthcare LLC (f/k/a BCPE Eagle Buyer LLC), a Delaware limited liability company, the lending institutions from time to time party thereto, Barclays Bank PLC, as the Administrative Agent, the Collateral Agent, a
Letter of Credit Issuer and a Lender and (ii) that certain Second Lien Credit Agreement, dated as of March 16, 2017 (as amended, restated, amended and restated, extended, supplemented or otherwise modified from time to time), among Aveanna
Healthcare Intermediate Holdings LLC (f/k/a BCPE Eagle Intermediate Holding, LLC), a Delaware limited liability company, Aveanna Healthcare LLC (f/k/a BCPE Eagle Buyer LLC), a Delaware limited liability company, the Lenders from time to time party
thereto and Royal Bank of Canada, as the Administrative Agent and the Collateral Agent, and the other parties party thereto. 

“Director Indemnification Agreements” has the meaning set forth in Section 2(d)(ii). 

“Effective Date” has the meaning set forth in the preamble of this Agreement. 

“Executives” has the meaning set forth in the preamble to this Agreement and means those officers, executives and employees
of, and other service providers to, the Company and its subsidiaries who acquire or are granted shares of the Company’s Common Stock and become a party to this Agreement. 

“Executive Chairman Director” has the meaning set forth in Section 2(a)(ii)(D). 

“Family Group” means, with respect to a Person who is an individual, (i) such individual’s spouse and descendants
(whether natural or adopted) (collectively, for purposes of this definition, “relatives”), (ii) such individual’s executor or personal representative, (iii) any trust, the trustee of which is such individual or such
individual’s executor or personal representative and which at all times is and remains solely for the benefit of such individual and/or such individual’s relatives, (iv) any corporation, limited partnership, limited liability company
or other tax flow-through entity the governing instruments of which provide that such individual or such individual’s executor or personal representative shall have the exclusive, nontransferable power to direct the management and policies of
such entity and of which the sole record and beneficial owners of stock, partnership interests, membership interests or any other equity interests are limited to such individual, such individual’s relatives and/or the trusts described in
clause (iii) above, and (v) any retirement plan for such individual. 
 “Independent Director” has the
meaning set forth in Section 2(a)(ii)(E). 

  
 3 

 “Independent Third Party” means any Person that, immediately prior to the
contemplated transaction, (i) does not own in excess of 10% of the voting Company Capital Stock on a fully-diluted basis (a “10% Owner”), and (ii) is not an Affiliate of or acting in concert with a 10% Owner and
(iii) is not part of the Family Group of a 10% Owner. 
 “IPO” means the initial underwritten Public Offering
consummated by the Company that resulted in shares of Common Stock that were sold in such Public Offering being listed on the NASDAQ Stock Market. 

“Joinder” has the meaning set forth in Section 7. 

“Major Sponsor” means a Sponsor whose Ownership Percentage is at least 25% of such Sponsor’s Original Ownership
Percentage. Any consent, approval, election or action taken or contemplated to be taken by the “Major Sponsors” or “each of the Major Sponsors” pursuant to this Agreement shall require the approval of each of (i) the Bain
Sponsors and (ii) the Whitney Sponsors (unless and until either or both have ceased to be a Major Sponsor pursuant to the preceding sentence). 

“Material Holder” means each Stockholder who holds at least 3% of the issued and outstanding shares of voting Company Capital
Stock on a fully diluted basis; provided, that for purposes of this definition, (i) the entities comprising the Bain Sponsors shall be aggregated for purposes of determining whether the Bain Sponsors collectively constitute a Material
Holder and (ii) the entities comprising the Whitney Sponsors shall be aggregated for purposes of determining whether the Whitney Sponsors collectively constitute a Material Holder. 

“Material Holder Sponsor” means a Sponsor who is a Material Holder. 

“Original Ownership Percentage” means a Stockholder’s Ownership Percentage as of the Effective Date after giving effect
to the PSA Healthcare Holding Distribution. 
 “Other Investors” has the meaning set forth in the preamble to this
Agreement. 
 “Other Stockholder” has the meaning set forth in Section 2(f). 

“Ownership Percentage” means, at such specified time, a fraction (expressed as a percentage) (i) the numerator of which
is the aggregate number of shares of Company Capital Stock owned by such Stockholder and its Affiliates and (ii) the denominator of which is the aggregate number of shares of Company Capital Stock owned by all Stockholders. 

“Permitted Transferees” means (i) with respect to Transfers by any Sponsor, to (x) any private equity fund
affiliated with or managed by such Sponsor or its Affiliates (and any investment vehicles wholly owned by such fund) and/or (y) any entity directly or indirectly wholly owned by any Person specified in clause (x) or (if applicable) any
direct or indirect general partner, managing member or similar control Person of any Person specified in clause (x) and (ii) with respect to Transfers by any Other Stockholder to an Affiliate of such Other Stockholder so long as such Affiliate
is either (A) wholly owned by such Other Stockholder, (B) directly or indirectly wholly owns such Other Stockholder, or (C) is a member of such Other Stockholder’s Family Group, so long as such Other Stockholder retains all
rights to vote, control and dispose of such Other Stockholder’s transferred Stockholder Shares. 
 “Person” means an
individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision
thereof. 

  
 4 

 “Principal Sponsor” means, as of any time of determination, a Sponsor whose
Ownership Percentage is at least 50% of such Sponsor’s Original Ownership Percentage. Any consent, approval, election or action taken or contemplated to be taken by the “Principal Sponsors” or “each of the Principal
Sponsors” pursuant to this Agreement shall require the approval of each of (i) the Bain Sponsors and (ii) the Whitney Sponsors (unless and until either or both have ceased to be a Principal Sponsor pursuant to the preceding sentence).

 “PSA Healthcare Holding” means PSA Healthcare Holding LLC, a Delaware limited liability company. 

“PSA Healthcare Holding Distribution” means the distribution by PSA Healthcare Holding, made as of the date hereof, of 100%
of its Common Stock to its equityholders. 
 “Public Offering” means any sale of Common Stock by the Company to the public
pursuant to an offering registered under the Securities Act. 
 “Public Sale” means any sale of Stockholder Shares to the
public pursuant to an offering registered under the Securities Act or to the public through a broker, dealer or market maker on a securities exchange or in the
over-the-counter market pursuant to the provisions of Rule 144 adopted under the Securities Act. 

“Registration Rights Agreement” has the meaning set forth in Section 4. 

“Relative Ownership Percentage” has the meaning set forth in Section 3(a)(iii). 

“Requisite Sponsor” means a Sponsor whose Ownership Percentage is at least 10% of such Sponsor’s Original Ownership
Percentage. Any consent, approval, election or action taken or contemplated to be taken by the “Requisite Sponsors” or “each of the Requisite Sponsors” pursuant to this Agreement shall require the approval of each of (i) the
Bain Sponsors and (ii) the Whitney Sponsors (unless and until either or both have ceased to be a Requisite Sponsor pursuant to the preceding sentence). 

“Rule 144” means such rule promulgated under the Securities Act by the Securities and Exchange Commission, as the same shall
be amended from time to time, or any successor rule then in force. 
 “Rule 144 Sale” means any sale of Stockholder Shares
to the public through a broker, dealer or market maker on a securities exchange or in the over-the-counter market pursuant to the provisions of Rule 144 adopted under
the Securities Act. 
 “Sale of the Company” means any transaction or series of transactions pursuant to which any
Independent Third Party or group of Independent Third Parties in the aggregate acquires (i) Company Capital Stock or Capital Stock of the surviving entity in a merger involving the Company, in each case, entitled to vote (other than voting
rights accruing only in the event of a default, breach, event of noncompliance or other contingency) to elect directors or managers with a majority of the voting power of the Company’s or the surviving entity’s board of directors or
managers (whether by merger, consolidation, reorganization, combination, sale or transfer of the Company’s Capital Stock) or (ii) all or substantially all of the Company’s assets determined on a consolidated basis; provided
that a Public Offering shall not constitute a Sale of the Company. 
 “Securities Act” means the Securities Act of 1933, as
amended from time to time, or any successor federal law then in force, together with all rules and regulations promulgated thereunder. 

  
 5 

 “Sponsors” means each of the Bain Sponsors, collectively, and the Whitney
Sponsors, collectively. References herein to ownership percentages and/or number of Stockholder Shares held by a Sponsor as of any time or date shall be deemed to be references to the collective ownership percentage and/or number of Stockholder
Shares held by all Persons constituting such Sponsor pursuant to the definition thereof as of such time or date; provided, for the avoidance of doubt, that any direct equity ownership in the Company by Rodney Windley, Tony Strange, Ed Reisz,
Jeffrey Shaner and any other Executives shall not be deemed to be owned by either the Bain Sponsors or the Whitney Sponsors. Any consent, approval, election or action taken or contemplated to be taken by “the Sponsors” or “each of the
Sponsors” pursuant to this Agreement shall require the approval of each of (i) the Bain Sponsors and (ii) the Whitney Sponsors. 

“Sponsor Business” has the meaning set forth in Section 10. 

“Sponsor Director” means each Whitney Director and each Bain Director. 

“Sponsor Group” has the meaning set forth in Section 10. 

“Stockholder Shares” means (i) any Company Capital Stock purchased or otherwise acquired by or issued to any Stockholder
and (ii) any Company Capital Stock issued or issuable with respect to the securities referred to in clause (i) above by way of stock dividend or stock split or in connection with a combination of shares, recapitalization, merger,
consolidation or other reorganization. As to any particular Stockholder Shares, such shares shall continue to be Stockholder Shares in the hands of transferees, except that such shares shall cease to be Stockholder Shares when they have been
disposed of pursuant to a Public Sale, a Sale of the Company or a Company Repurchase. 
 “Stockholders” has the meaning set
forth in the preamble of this Agreement. 
 “Transfer” has the meaning set forth in
Section 3(a)(i) 
 “Whitney Directors” has the meaning set forth in
Section 2(a)(ii)(B). 
 “Whitney Independent Director” has the meaning set forth in
Section 2(a)(ii)(B). 
 “Whitney VII” has the meaning set forth in
Section 2(a)(ii)(B). 
 “Whitney VII VCOC Director” has the meaning set forth in
Section 2(a)(ii)(B). 
 “Whitney Employee/Designee Director” has the meaning set forth in
Section 2(a)(ii)(B). 
 “Whitney Sponsors” means J.H. Whitney VII, L.P., PSA Healthcare
Investment Holding LLC, PSA Iliad Holdings LLC, JHW Iliad Holdings LLC and JHW Iliad Holdings II LLC (in the case of each of PSA Healthcare Investment Holding LLC, PSA Iliad Holdings LLC, JHW Iliad Holdings LLC and JHW Iliad Holdings II LLC which
shall at all times be controlled by funds and investment vehicles managed by J.H. Whitney Capital Partners, LLC) and each of their Permitted Transferees that acquires Stockholder Shares and becomes a Stockholder hereunder and each of their
Affiliates that acquires Stockholder Shares and becomes a Sponsor hereunder in accordance with the terms hereof. Unless otherwise agreed by the holder(s) of a majority of the Stockholder Shares collectively held by the Whitney Sponsors, any consent,
approval, election or action taken or contemplated to be taken by the Whitney Sponsors pursuant to this Agreement shall be taken by the holder(s) of a majority of the Stockholder Shares collectively held by the Whitney Sponsors at such time. 

  
 6 

 Section 2. Board of Directors. 

(a) Election of Directors. From and after the Effective Date and until the provisions of this Section 2(a) cease to be effective in
accordance with Section 2(e), each holder of Stockholder Shares shall vote all of such holder’s Stockholder Shares that are voting shares and any other voting securities of the Company over which such holder has voting control and shall
take all other necessary or desirable actions within such holder’s control reasonably requested in good faith by the Material Holder Sponsors (whether in such holder’s capacity as a stockholder, director, member of a Board committee or
officer of the Company or otherwise, and including, without limitation, attendance at meetings in person or by proxy for purposes of obtaining a quorum and execution of written consents in lieu of meetings) and the Company shall take, and shall
cause its subsidiaries to take, all necessary or desirable actions within its control reasonably requested in good faith by the Material Holder Sponsors (including, without limitation, calling special Board and stockholders meetings), so
that, subject to Section 2(c) below: 
 (i) the authorized number of directors on the Board shall be eleven
(11) directors (or such greater or lesser number of directors as jointly determined from time to time by the Sponsors); 
 (ii) subject
to Section 2(c) below, the following individuals shall be elected to the Board: 
 (A) 4 directors designated by
the Bain Sponsors, of which one (the “Bain XI VCOC Director”) will be an employee of the Bain Sponsors or their Affiliates and designated by Bain Capital Fund XI, L.P. (the “Bain XI VCOC”), who shall be initially
Christopher Gordon, one (the “Bain Employee Director”) will be an employee of the Bain Sponsors or their Affiliates and designated by the Bain Sponsors, who shall be initially Devin O’Reilly, and two (the “Bain
Independent Directors”) will be independent directors designated by the Bain Sponsors, one of whom will initially be Richard C. Zoretic with the other Bain Independent Director position to remain vacant as of the Effective Date
(collectively with their respective successors as the Bain Sponsors may appoint from time to time in accordance with the terms and conditions of this Agreement, the “Bain Directors”); 

(B) 4 directors designated by the Whitney Sponsors, of which one (the “Whitney VII VCOC Director”) will be an employee of the
Whitney Sponsors or their Affiliates and designated by J.H. Whitney VII, L.P. (“Whitney VII”), who shall be initially Robert M. Williams, Jr., one (the “Whitney Employee/Designee Director”) will be an employee or
other designee of the Whitney Sponsors or their Affiliates and designated by Whitney VII, who shall be initially Steven Rodgers, and two (the “Whitney Independent Directors”) will be independent directors designated by the Whitney
Sponsors, one of whom shall initially be Sheldon Retchin with the other Whitney Independent Director position to remain vacant as of the Effective Date (collectively with their respective successors as Whitney VII and the Whitney Sponsors, as
applicable, may appoint from time to time in accordance with the terms and conditions of this Agreement, the “Whitney Directors”); 

(C) the Chief Executive Officer of the Company, for so long as such person remains the Chief Executive Officer of the Company (the
“CEO Director”); 
 (D) the Executive Chairman of the Company, for so long as such person remains the Executive Chairman of
the Company (the “Executive Chairman Director”); and 
 (E) 1 independent director designated jointly by the
Requisite Sponsors, the CEO Director and the Executive Chairman Director (the “Independent Director”), who shall not be deemed to be a designee of either Sponsor, who shall be initially Victor Ganzi. 

  
 7 

 (iii) unless otherwise agreed in writing by the Requisite Sponsors, (A) any committees
of the Board shall be created only upon the approval of the Board (including, for so long as a Sponsor is a Requisite Sponsor, approval by at least one director appointed by such Sponsor (other than the Bain Independent Directors and Whitney
Independent Directors, as applicable)) and (B) the composition of, and voting rights with respect to, each such committee shall be proportionately equivalent to that of the Board; 

(iv) unless otherwise agreed in writing by the Requisite Sponsors, the composition of, and voting rights with respect to, the board of
directors or other governing body of each of the Company’s subsidiaries, including any committees thereof, shall be proportionately equivalent to that of the Board; 

(v) subject to Section 2(a)(ix) and Section 2(c), the removal from the Board (with or
without cause) of (A) the Bain XI VCOC Director shall be at the Bain XI VCOC’s written direction and (B) any of the other Bain Directors shall be at the Bain Sponsors’ written direction, but only upon such written direction and
under no other circumstances; 
 (vi) subject to Section 2(a)(ix) and Section 2(c), the
removal from the Board (with or without cause) of (A) the Whitney VII VCOC Director shall be at Whitney VII’s written direction, (B) of the Whitney Employee/Designee Director shall be at Whitney VII’s written direction and
(C) of the Whitney Independent Directors shall be at the Whitney Sponsors’ written direction, but, in each case, only upon such written direction and under no other circumstances; 

(vii) the CEO Director shall automatically be removed from the Board in connection with the cessation or termination of his or her employment
with the Company, and such individual shall be replaced by the subsequent Chief Executive Officer of the Company unless otherwise jointly determined by the Requisite Sponsors; 

(viii) the Executive Chairman Director shall automatically be removed from the Board in connection with the cessation or termination of his or
her service as Executive Chairman of the Company, and such individual shall be replaced by the subsequent Executive Chairman of the Company unless otherwise jointly determined by the Requisite Sponsors; 

(ix) to the extent that, pursuant to Section 2(c), a Sponsor loses its rights to designate one or more Sponsor
Directors to the Board, then such Sponsor shall also lose the corresponding rights to designate representatives to committees of the Board and to the boards and similar governing bodies of the Company’s subsidiaries as provided in
Section 2(a)(iv) and Section 2(a)(v); and 
 (x) subject to
Section 2(a)(ix), Section 2(b)(i) and Section 2(c), in the event that any director designated hereunder ceases to serve as a member of the Board during his or her term of
office, the resulting vacancy on the Board shall be filled by a representative designated by the Bain XI VCOC, the Bain Sponsors, the Whitney Sponsors, Whitney VII or jointly by the Requisite Sponsors, the CEO Director and the Executive Chairman
Director, as applicable, as provided hereunder and subject to the limitations contained herein (including with respect to the Sponsors’ right to appoint directors hereunder). 

(b) Board Composition; Quorum; Voting. 

(i) Board Composition. Except as expressly set forth herein, the composition of the Board may be changed only upon the written
agreement of the Principal Sponsors (provided that Board appointment rights expressly granted pursuant to Section 2(a)(ii), except as set forth in Section 2(c), may only be modified upon the
written agreement of the Requisite Sponsors). Unless otherwise agreed in writing by the Principal Sponsors, if the number of directors on the Board that a Sponsor is entitled to appoint is decreased as described in
Section 2(c) below, the size of the Board shall be automatically decreased by the same number of directors that such Sponsor is no longer entitled to appoint. 

  
 8 

 (ii) Classes of Directors. 

(A) The name of the persons who are to serve as directors in each class effective as of the date of the Certificate of Incorporation and until
their successors are elected and qualified are as follows: 
  

					
	 Name
	  	Position, Director Class	  	Expiration of Initial Term
	 Devin O’Reilly
	  	Class I Director	  	2022
	 Robert M. Williams, Jr.
	  	Class I Director	  	2022
	 Victor Ganzi
	  	Class I Director	  	2022
	 Christopher Gordon
	  	Class II Director	  	2023
	 Steven Rodgers
	  	Class II Director	  	2023
	 Rodney Windley
	  	Class II Director	  	2023
	 Other Bain Independent Director (vacant as of the Effective Date)
	  	Class II Director	  	2023
	 Richard Zoretic
	  	Class III Director	  	2024
	 Shelden Retchin
	  	Class III Director	  	2024
	 H. Anthony Strange
	  	Class III Director	  	2024
	 Other Whitney Independent Director (vacant as of the Effective Date)
	  	Class III Director	  	2024

 (iii) Quorum. At every meeting of the Board or a committee thereof, a quorum shall require the
attendance, whether in person, telephonically or in any other manner permitted by applicable law and the Certificate of Incorporation, of (i) the number of directors representing a majority of the voting power of the Board or such committee and
(ii) at least one director designated by each of the Requisite Sponsors (other than the Bain Independent Directors and Whitney Independent Directors, as applicable). 

(iv) Voting. Board and Board committee action at a meeting at which a quorum is established shall require approval by a majority of the
directors. Each member of the Board or such committee will have one vote. The Board or any committee thereof may also take action without a meeting by unanimous written consent, as more fully set forth in the Certificate of Incorporation. 

  
 9 

 (c) Limitation on Board Appointment Rights. The right of the Sponsors to designate
any directors pursuant to Section 2(a)(ii) shall be subject to the following; provided that, for purposes of calculating the relative Ownership Percentages below, the effects of (x) any recapitalization or
exchange or conversion of Stockholder Shares, (y) any redemption or repurchase of Stockholder Shares or (z) any subdivision (by stock split or otherwise) or any combination (by reverse stock split or otherwise) of any outstanding
Stockholder Shares, in each case, which occurs between the Effective Date and the date of such calculation and which is pro rata in effect shall not be taken into account in such calculation; provided further that, for so long
as the Bain Sponsors hold a number of Stockholder Shares equal to or greater than the number of Stockholder Shares held by the Whitney Sponsors, there shall not be fewer Bain Directors than Whitney Directors: 

(i) each Principal Sponsor shall have the right to designate 4 directors pursuant to Section 2(a)(ii) above (or such
other number as determined in accordance with Section 2(b)(i) above) for appointment to the Board until such time as such Principal Sponsor ceases to be a Principal Sponsor, at which time such Sponsor will lose the right to
appoint one director to the Board; provided that, such appointment right so lost shall be with respect to one Bain Independent Director or one Whitney Independent Director, as applicable; 

(ii) each Major Sponsor shall have the right to designate 3 directors pursuant to Section 2(a)(ii) above (or such
other number as determined in accordance with Section 2(b)(i) above) for appointment to the Board until such time as such Major Sponsor ceases to be a Major Sponsor, at which time such Sponsor will lose the right to appoint
the second Bain Independent Director or the second Whitney Independent Director, as applicable; 
 (iii) each Requisite Sponsor shall have
the right to designate 2 directors pursuant to Section 2(a)(ii) above (or such other number as determined in accordance with Section 2(b)(i) above) for appointment to the Board until such time as
such Requisite Sponsor ceases to be a Requisite Sponsor, at which time such Sponsor will lose the right to appoint the Bain Employee Director or the Whitney Employee/Designee Director, as applicable; 

(iv) each Material Holder Sponsor shall have the right to designate 1 director pursuant to Section 2(a)(ii) above
(or such other number as determined in accordance with Section 2(b)(i) above) for appointment to the Board until such time as such Material Holder Sponsor ceases to be a Material Holder Sponsor, at which time such Sponsor
will not have the right to appoint any directors to the Board. 
 (d) Director Expenses, Indemnification. 

(i) The Company shall pay the reasonable out-of-pocket
expenses incurred by each director in connection with attending the meetings of the Board and any committee thereof. 
 (ii) So long as any
Sponsor Director serves on the Board, the Company shall maintain directors’ and officers’ indemnity insurance coverage reasonably satisfactory to each of the Requisite Sponsors, the Company’s Certificate of Incorporation and bylaws
shall provide for indemnification and exculpation of directors to the fullest extent permitted under applicable law and each Sponsor Director shall be offered an indemnification agreement with the Company (a “Director Indemnification
Agreement”) that is substantively the same as the indemnification agreements that the other Sponsor Directors have been offered with the Company. 

(e) Termination. The provisions of Section 2(a)–(d)(i) shall terminate automatically and be of no further
force and effect upon the first to occur of (i) a Sale of the Company and (ii) when neither Sponsor is a Material Holder Sponsor. 

  
 10 

 (f) Voting of Shares; Proxy. From and after the date hereof, each Executive and each
Other Investor (each, an “Other Stockholder”) hereby agrees to cast (or cause to be cast) all votes (if any) to which such Other Stockholder is entitled in respect of its Stockholder Shares, at any annual or special meeting, by
written consent or otherwise, and shall take all other necessary or desirable actions (including attendance at meetings in person or by proxy for purposes of obtaining a quorum, execution of written consents in lieu of meetings and approval of
amendments and/or restatements of the Company’s certificate of incorporation or by-laws), in each case to effectuate any corporate action on the part of the Company or any of its subsidiaries that has
been approved by the Board and/or the Major Sponsors in accordance with the terms of this Agreement and the Company’s or such subsidiaries’ organizational documents. Without limiting the generality of the foregoing, each Other Stockholder
agrees as follows: 
 (i) Certificate of Incorporation Amendments. Any amendments or modifications to the Certificate of
Incorporation before the Trigger Event (as defined in the Certificate of Incorporation) shall require the consent of the Major Sponsors. Each Other Stockholder agrees to cast all votes (if any) to which such Other Stockholder is entitled in respect
of its Stockholder Shares, whether at any annual or special meeting, by written consent or otherwise, in such manner as the Board or the Major Sponsors may instruct by written notice to approve any amendment to the Certificate of Incorporation that
is approved by the Board and the Major Sponsors in accordance with (and subject to the terms and conditions of) this Agreement, the Certificate of Incorporation and Delaware law. 

(ii) Proxy. In order to secure the obligations of each Other Stockholder to vote such Other Stockholder’s voting Stockholder
Shares in accordance with the provisions of this Agreement, each Other Stockholder hereby irrevocably grants to and appoints the Major Sponsors, acting jointly through one or more representatives of such Major Sponsors, such Other Stockholder’s
proxy and attorney-in-fact, with full power of substitution, for and in the name, place and stead of such Other Stockholder, to vote or act by written consent with
respect to such Other Stockholder’s voting Stockholder Shares, in each case in accordance with this Agreement. The power and authority to exercise the proxy granted hereby shall be exercised if and only if the matter to be voted on or with
respect to which other stockholder action is to be taken has been approved by the Board (including at least one director appointed by each Major Sponsor (other than the Bain Independent Directors and Whitney Independent Directors, as applicable))
and shall be exercised on terms consistent with such approval. Each Other Stockholder agrees that the irrevocable proxy set forth in this Section 2(f) shall survive the death, incompetency, disability, dissolution or
bankruptcy of such Other Stockholder and the subsequent holders of such voting Stockholder Shares. Each Other Stockholder hereby further agrees and affirms that the proxy granted hereunder is irrevocable and coupled with an interest sufficient at
law to support an irrevocable proxy. 
 Section 3. Restrictions on Transfer of Stockholder Shares. 

(a) Transfer of Stockholder Shares. 

(i) Public Transfers. Following the consummation of the IPO, any Stockholder may, subject to the terms of the Registration Rights
Agreement, sell, transfer, assign, pledge or otherwise directly or indirectly dispose of, whether with or without consideration and whether voluntarily or involuntarily or by operation of law (“Transfer” or, if used as a noun, a
“Transfer”) any or all of such Stockholder’s Stockholder Shares without the consent of any other Person in a Public Sale; provided, that (x) in the case of an Other Stockholder, such Other Stockholder may only
Transfer to the extent such Transfer would not result in the Relative Ownership Percentage of such Other Stockholder immediately following such Transfer being less than the Relative Ownership Percentage of the Sponsors immediately following such
Transfer and (y) if, due to this Agreement, the Registration Rights Agreement or any other agreement, any Stockholders are deemed to constitute a single group for purposes of Rule 144 during any volume limit measurement period thereunder, such
Stockholders will not be permitted to Transfer pursuant 

  
 11 

 
to Rule 144 during such measurement period more than their pro rata portion (determined, as of the commencement of such measurement period, as the percentage equal to (1) such
Stockholder’s aggregate number of Stockholder Shares divided by (2) the applicable Stockholders’ aggregate number of Stockholder Shares) of the aggregate number of Stockholder Shares that may be Transferred by such Stockholders within
the constraints of such volume limit during such measurement period and (y) any Transfer by a Sponsor pursuant to this paragraph occurring during the Coordination Period shall not be made without Coordination Committee approval in accordance
with Section 8. For the purposes of this Section 3(a)(i), “Relative Ownership Percentage” shall mean (A) with respect to the Stockholder Shares held by an Other Stockholder, a fraction (expressed
as a percentage) (i) the numerator of which is the number of Stockholder Shares owned by such Other Stockholder immediately following the effective time of a Transfer and (ii) the denominator of which is the aggregate number of Stockholder
Shares owned by such Other Stockholder at the time of the consummation of the IPO and (B) with respect to the Stockholder Shares held by the Sponsors, a fraction (expressed as a percentage) (i) the numerator of which is the aggregate
number of Stockholder Shares owned by all of the Sponsors immediately following the effective time of such Transfer and (ii) the denominator of which is the aggregate number of Stockholder Shares owned by all of the Sponsors at the time of the
consummation of the IPO. 
 (ii) Cooperation. In connection with a proposed Transfer of Stockholder Shares by a Sponsor (after having
received any approval of the Coordination Committee to the extent required under Section 8), the Company will provide, and will cause its controlled Affiliates to provide, such cooperation as may be reasonably requested by such Sponsor in
connection with the prospective purchaser’s due diligence investigation of the Company and its controlled Affiliates, including providing such proposed purchaser with reasonable access to the material contracts, properties, books and records of
the Company and its controlled Affiliates and reasonable access to management on reasonable notice, subject to any such prospective purchaser entering into a customary confidentiality agreement in favor of the Company. 

(b) Permitted Transfers. The restrictions set forth in this Section 3 shall not apply with respect to
Transfers by any Sponsor to a Permitted Transferee; provided, however, that in no event shall any of the following Transfers of shares of Capital Stock be a Transfer to a Permitted Transferee: (1) any direct or indirect Transfer
of shares of Company Capital Stock (or beneficial or economic interest in any shares of Company Capital Stock) to a co-investment or similar vehicle and/or (2) any direct or indirect Transfer of any
shares of Capital Stock (or beneficial or economic interest in any shares of Company Capital Stock) to any successor private equity fund affiliated with, or sponsored or managed by, a transferring Sponsor or any of its Affiliates or ultimate
controlling persons; provided, further, that, in each case, any Transfer to such Permitted Transferees shall be conditioned on the receipt of an undertaking by such Permitted Transferee to Transfer such Stockholder Shares back to the
transferor if such Permitted Transferee ceases to otherwise qualify as a Permitted Transferee. In addition, no Permitted Transferee may be a Competitor of the Company. The restrictions contained in this Section 3 shall
continue to be applicable to the Stockholder Shares after any Transfer thereof, and the transferees of such Stockholder Shares must, as a condition to such Transfer thereof, agree in writing to be bound by the provisions of this Agreement affecting
the Stockholder Shares so Transferred. Notwithstanding the foregoing, no party hereto shall avoid the provisions of this Agreement by (x) making one or more Transfers to one or more Permitted Transferees and then disposing of all or any portion
of such party’s interest in any such Permitted Transferee or (y) any Transfer of the securities of, or the merger or consolidation of, any entity holding (directly or indirectly) Stockholder Shares. For the avoidance of doubt, it is
understood that, (i) with respect to the Whitney Sponsors and the Bain Sponsors, a bona fide direct or indirect transfer of limited partnership interests in a limited partnership private equity fund affiliated with or managed by Bain Capital
Private Equity, LP or J.H. Whitney Capital Partners, LLC or their respective Affiliates, as the case may be, or of any Person that holds a direct or indirect interest in such private equity fund, to another partner or to a third party shall not be
deemed a Transfer and (ii) with respect to Hamilton Lane Co-Investment Fund III Holdings-2 LP, PEA 

  
 12 

 
Washington Holdings LP, Penfund Fund V Equity Holding Limited Partnership, PSA Holding LP and NB SOF III Holdings LP, (A) a bona fide direct or indirect transfer of limited partnership
interests in a limited partnership private equity fund affiliated with or managed by an Affiliate of such holder shall not be deemed a Transfer and (B) a bona fide transfer of equity interests in a Sponsor by a holder thereof to an Affiliate of
such holder shall not be deemed a Transfer, provided that, in each case of clauses (i) and (ii), no Person may make any such Transfer to the extent such transaction has the result and effect of a Stockholder hereunder avoiding the
restrictions on Transfers in this Agreement. 
 (c) Newco Transfers. Each Sponsor (or holding entity thereof) that is formed for the
purpose of making an investment in the Company or for which the ownership interest in the Company constitutes a substantial portion of the assets of such Sponsor (or holding entity thereof) (each of PSA Investment Healthcare Holding, PSA Iliad
Holdings LLC, JHW Iliad Holdings LLC, JHW Iliad Holdings II LLC and any other such Sponsor (or holding entity thereof), a “Newco Sponsor”) shall not permit any Transfer of Capital Stock of such Newco Sponsor or the issuance of
Capital Stock in such Newco Sponsor to the extent such Transfer has the effect of avoiding the restrictions on Transfers in this Agreement (it being understood that the purpose of this Section 3(c) is to prohibit the
Transfer of Capital Stock of such Newco Sponsor or issuance of Capital Stock in such Newco Sponsor that has the result and effect that the Newco Sponsor has indirectly made a Transfer or issuance that would not have been directly permitted as a
Transfer under this Agreement). 
 (d) Termination of Restrictions. The restrictions on the Transfer of Stockholder Shares set forth
in this Section 3 shall continue with respect to each Stockholder Share until the date on which such Stockholder Share has been Transferred in a Public Sale or pursuant to a Sale of the Company. 

Section 4. Registration Rights. Concurrently with the execution of this Agreement, each Stockholder has entered into the amended
and restated registration rights agreement in the form attached hereto as Exhibit B (the “Registration Rights Agreement”). 

Section 5. Legend. Each certificate or book entry evidencing Stockholder Shares and each certificate issued in exchange for or
upon the Transfer of any Stockholder Shares (if such shares remain Stockholder Shares as defined herein after such Transfer) shall be stamped, imprinted or otherwise notated with a legend in substantially the following form: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN AMENDED AND RESTATED STOCKHOLDERS AGREEMENT DATED AS OF [_____], 2021,
AS AMENDED FROM TIME TO TIME, AMONG THE ISSUER OF SUCH SECURITIES (THE “COMPANY”) AND CERTAIN OF THE COMPANY’S STOCKHOLDERS. A COPY OF SUCH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT AS AMENDED FROM TIME TO TIME WILL BE
FURNISHED WITHOUT CHARGE BY THE COMPANY TO THE HOLDER HEREOF UPON WRITTEN REQUEST.” 
 Upon the Transfer of any Stockholder Shares, the restrictive
legend set forth above shall be removed from the certificate or book entry representing such shares if such shares cease to be Stockholder Shares as provided in the definition of such term in Section 1. 

Section 6. Transfers in Violation of Agreement. Any Transfer or attempted Transfer of any Stockholder Shares in violation of any
provision of this Agreement shall be null and void ab initio, and the Company shall not record such Transfer on its books or treat any purported transferee of such Stockholder Shares as the owner of such shares for any purpose. 

  
 13 

 Section 7. Additional Parties; Joinder. As a condition to any Transfer of
Stockholder Shares after which Transfer such shares remain Stockholder Shares as provided in the definition of such term in Section 1, the Company shall require such Person, if not already a party to this Agreement, to
become a party to this Agreement and to succeed to and become bound by all of the rights and obligations of a “Stockholder” and a “holder of Stockholder Shares” under this Agreement by executing a joinder to this Agreement from
such Person in the form of Exhibit A attached hereto (a “Joinder”). The Company Capital Stock acquired by such Person (the “Acquired Shares”) shall be included as Stockholder Shares
hereunder, such Person shall be a “Sponsor”, an “Executive” or an “Other Investor”, as designated on such Joinder, and a “holder of Stockholder Shares” under this Agreement with respect to the Acquired Shares,
and the Company shall add such Person’s name and address to the appropriate schedule hereto. 
 Section 8. Coordination
Committee. The Requisite Sponsors will form a coordination committee (the “Coordination Committee”) in connection with the closing of the IPO and will thereafter maintain such committee until the end of the Coordination Period.
Unless otherwise agreed in writing by the Requisite Sponsors, the Coordination Committee shall be composed of the Bain Employee Director, the Bain XI VCOC Director, the Whitney VII VCOC Director and the Whitney Employee/Designee Director. The
Coordination Committee shall determine, from time to time, the procedures which govern the conduct of the Coordination Committee. In connection with the IPO and during the Coordination Period, no Sponsor shall directly or indirectly Transfer any
Shares to any Person (other than a Permitted Transferee), without the prior approval of each of the members of the Coordination Committee. No Requisite Sponsor shall agree to or be granted any waiver or release from the Transfer restriction in the
foregoing sentence (whether imposed by underwriters, the Coordination Committee or otherwise) unless such waiver or release is provided to the other Requisite Sponsors in the same form and proportion. 

Section 9. Confidentiality. 

(a) Each Sponsor Director is hereby authorized by the Company to share information regarding the Company and its subsidiaries obtained in
connection with such individual’s service as a Sponsor Director with the agents, advisors, representatives and investment professionals employed or engaged by the Sponsor designating such Sponsor Director (or by any of such Sponsor’s
Affiliates). The designating Sponsor shall be responsible for maintaining the confidentiality of such information given to such agents, advisors, representatives and investment professionals. Each Sponsor is hereby authorized by the Company to
provide summary financial information regarding the Company and its subsidiaries as part of such Sponsor’s (or its Affiliates’) normal reporting, rating or review procedure (including normal credit rating and pricing process), or in
connection with such Sponsor’s (or its Affiliates’) normal fund raising, marketing, informational or reporting activities. In addition, no Sponsor Director shall be required to disclose to the Board or the Company any confidential
information regarding the Sponsor Director’s designating Sponsor or its Affiliates. 
 (b) Without limiting the Sponsor Directors’
rights under Section 9(a), each Stockholder agrees that it will keep confidential and will not disclose, divulge or use for any purpose, other than to monitor its investment in the Company or in the good faith performance
of such Stockholder’s duties to the Company, any Confidential Information; provided, however, that a Stockholder may disclose Confidential Information: (A) to its attorneys, accountants, consultants, and other professionals
to the extent necessary to obtain their services in connection with monitoring its investment in the Company; (B) to any Affiliate, partner or member of such Stockholder in the ordinary course of business; (C) upon the written consent of
the Board; or (D) as may otherwise be required by law; provided, that such party takes reasonable steps to minimize the extent of any such required disclosure; provided, further, that the acts and omissions of any Person to
whom such Stockholder may disclose Confidential Information pursuant to clauses (A) and (B) of the preceding proviso shall be attributable to such Stockholder for purposes of determining such party’s compliance with this
Section 9. 
 (c) Notwithstanding the foregoing, the Company and each Stockholder acknowledges that, (x) in
the ordinary course of business of each member of the Sponsor Group, the members of the Sponsor Group evaluate, pursue, acquire, sell, manage, advise and serve on the boards of other Persons, (y) the review of the Confidential Information by
each of the Sponsors and the members of the Sponsor Group may inevitably enhance such Persons’ or their respective Affiliates’ knowledge and understanding of the industries in which the Company and its subsidiaries operate in a way that
cannot be separated from such Persons’ or their respective Affiliates’ other knowledge, and the Company and each Stockholder agrees that this Section 9 shall not restrict such Persons’ or their respective
Affiliates’ use of such general industry knowledge and understanding, including in connection with investments in other companies (including in the same or similar industries) and (z) none of the Sponsors or any member of the Sponsor Group
shall be deemed to have used any Confidential Information in contravention of this Section 9 solely because of the fact of its evaluation, pursuit, acquisition, sale or management of, provision of advice to, or service on
the board of any such other investment. In addition, no Sponsor Director shall be required to disclose to the Board or the Company any confidential information regarding the Sponsor Director’s designating Sponsor or its Affiliates or any of
such Sponsor Director’s employer, investment firm or other enterprise. 

  
 14 

 Section 10. Corporate Opportunity Waiver. Each Stockholder acknowledges and
agrees that: (a) the Sponsors and their respective Affiliates, investment funds and vehicles, equityholders, directors, director designees (and such designees’ employers, investment firms or other enterprises), officers, controlling
persons, partners, managers, members and employees (collectively, the “Sponsor Group”) (i) have investments or other business relationships with entities engaged in other businesses (including those which may compete with the
business of the Company and its subsidiaries or areas in which the Company and its subsidiaries may in the future engage in businesses) and in related businesses other than through the Company and its subsidiaries (each, a “Sponsor
Business”), (ii) may develop a strategic relationship with businesses that are or may be competitive with the Company and its subsidiaries and (iii) will not be prohibited by virtue of its investment in the Company and its
subsidiaries, or its service on the Board or any board of directors, board of managers or similar governing body of any subsidiary of the Company, or right to appoint any person to serve on the Board or any other such board or similar governing
body, from pursuing and engaging in any such activities; (b) neither the Company or its subsidiaries nor any other Stockholder shall have any right in or to such other ventures or activities or to the income or proceeds derived therefrom; and
(c) no member of the Sponsor Group shall have any duty (fiduciary, contractual or otherwise) or otherwise be obligated to present any particular investment or business opportunity to the Company or its subsidiaries even if such opportunity is
of a character which, if presented to the Company or its subsidiaries, could be undertaken by the Company or its subsidiaries, and each member of the Sponsor Group shall have the right to undertake any such opportunity for itself for its own account
or on behalf of another or to recommend any such opportunity to other Persons; provided, that none of the foregoing clauses (a) through (c) shall apply to any Person who is a full-time employee of the Company or any of its Subsidiaries
or otherwise limit or amend any obligations under any agreement to which a Stockholder or any of its Affiliates is a party. Each of the Company, on behalf of itself and its subsidiaries, and each Stockholder hereby waives, to the fullest extent
permitted by applicable law, any claims and rights that such person may otherwise have in connection with the matters described in this Section 10. 

Section 11. General Provisions. 

(a) Amendments and Waivers; Termination. Except as otherwise provided herein, the provisions of this Agreement may be amended,
modified or waived only with the prior written consent of each Sponsor holding at least 1% of the outstanding shares of voting Company Capital Stock on a fully-diluted basis; provided that no such amendment, modification or waiver that by its
terms would materially and adversely affect a holder or group of holders of Stockholder Shares in a manner materially different than any other holder or group of holders of Stockholder Shares shall be effective against such holder or group of
holders of Stockholder Shares without the consent of the holders of a majority of the Stockholder Shares that are held by the group of holders that is materially and adversely affected thereby. The failure or delay of any Person to enforce any of
the provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall not affect the right of such Person thereafter to enforce each and every provision of this Agreement in accordance with its terms. A waiver or
consent to or of any breach or default by any Person in the performance by that Person of his, her or its obligations under this Agreement shall not be deemed to be a consent or waiver to or of any other breach or default in the performance by that
Person of the same or any other obligations of that Person under this Agreement. Notwithstanding anything to the contrary herein, (i) no amendment to this Agreement in connection with an additional investment or a new investor shall be deemed
to adversely affect any class of Company Capital Stock merely because of the addition of such new investor or amendments to account for the addition of such new investor or the terms of such investment, and, for the avoidance of doubt, differences
resulting from Stockholders holding different amounts or classes of Company Capital Stock will not be deemed materially different for any purposes under this Agreement and (ii) this Agreement shall terminate upon a Sale of the Company, subject
to compliance with the terms of this Agreement in connection with such Sale of the Company. 
 (b) Remedies. The parties to this
Agreement shall be entitled to enforce their rights under this Agreement by specific performance, injunctive relief and other equitable remedies (without posting a bond or other security or proving insufficiency of damages), to recover damages
caused by reason of any breach of any provision of this Agreement and to exercise all other rights existing in their favor. The parties agree and acknowledge that (i) the Company and the Stockholder Shares are unique, (ii) a breach of this
Agreement would cause substantial and irreparable harm to the Company and the non-breaching parties, (iii) money damages would not be an adequate remedy for any such breach and (iv) in addition to
any other rights and remedies existing hereunder, any party shall be entitled to specific performance, other injunctive relief and other equitable remedies from any court of law or equity of competent jurisdiction (without posting any bond or other
security or proving insufficiency of damages) in order to enforce or prevent any violation of the provisions of this Agreement. 
 (c)
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited, invalid, illegal or
unenforceable in any respect under any applicable law or regulation in any jurisdiction, such prohibition, invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of any other provision of this Agreement
in such jurisdiction or in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such prohibited, invalid, illegal or unenforceable provision had never been contained herein. 

  
 15 

 (d) Entire Agreement. Except as otherwise provided herein and in the Certificate of
Incorporation, the Company’s bylaws, the Registration Rights Agreement, this Agreement (including all schedules, exhibits and annexes hereto) contains the complete agreement and understanding among the parties hereto with respect to the subject
matter hereof and supersedes and preempts any prior understandings, agreements or representations by or among the parties hereto, written or oral, which may have related to the subject matter hereof in any way. 

(e) Successors and Assigns. Except as otherwise provided herein, this Agreement shall bind and inure to the benefit of and be
enforceable by the Company and its successors and permitted assigns and the holders of Stockholder Shares and their respective successors and permitted assigns (whether so expressed or not), so long as such Persons hold Stockholder Shares. Neither
the Company nor 

  
 16 

 
any Stockholder may assign this Agreement, any interest herein or any right or obligation hereunder without the prior written consent of each of the Sponsors, except in a Transfer pursuant to
Section 3(a)(i). Except as otherwise set forth herein, the provisions of this Agreement which are for the benefit of purchasers or holders of Stockholder Shares are also for the benefit of, and enforceable by, any
subsequent holder of Stockholder Shares. 
 (f) Notices. Any notice, demand or other communication to be given under or by reason of
the provisions of this Agreement shall be in writing and shall be deemed to have been given (i) when delivered personally to the recipient, (ii) when sent to the recipient by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient on a Business Day, but if not, then on the next Business Day, (iii) one Business Day after it is sent to the recipient by reputable overnight courier service (charges prepaid) or (iv) 3 Business Days after
it is deposited in the U.S. Mail, postage pre-paid, addressed to the recipient, first-class mail, return receipt requested. Such notices, demands and other communications shall be sent to the Company at the
address specified below and to any holder of Stockholder Shares or to any other party subject to this Agreement at such address as indicated on the applicable schedule hereto, or at such address or to the attention of such other Person as the
recipient party has specified by prior written notice to the sending party. Any party may change such party’s address for receipt of notice by giving written notice of the change to the sending party as provided herein. 

To the Company: 
 Six
Concourse Parkway 
 Suite 1100 

Atlanta, GA 30328 
 Attention:
Chief Executive Officer 
 Facsimile No.: (770) 248-8192 

with copies (which shall not constitute notice) to the Whitney Sponsors and the Bain Sponsors. 

To any Whitney Sponsor: 

c/o J.H. Whitney Capital Partners, LLC 

130 Main Street 
 New Canaan, CT
06840 
 Attention: Robert M. Williams, Jr. 

Facsimile No.: (203) 716-6217 

Email: rwilliams@whitney.com and 

           dzatlukal@whitney.com 

with a copy (which shall not constitute notice) to: 

Dechert LLP 
 1095 Avenue of the
Americas 
 New York, NY 10036-6797 

Attention: Markus Bolsinger 

Facsimile No.: (212) 698-3599 

Email: markus.bolsinger@dechert.com 

To any Bain Sponsor: 

  
 17 

 c/o Bain Capital Private Equity, LP 

200 Clarendon Street 
 Boston, MA
02116 
 Attention: Christopher Gordon, Devin O’Reilly, Paul Moskowitz and David Hutchins 

Facsimile No.: (617) 516-2010 

Email: cgordon@baincapital.com, DOReilly@baincapital.com, pmoskowitz@baincapital.com and dhutchins@baincapital.com 

with a copy (which shall not constitute notice) to: 

Kirkland & Ellis LLP 

300 North LaSalle 
 Chicago, IL
60654 
 Attention: Matthew H. O’Brien, P.C. and Christopher R. Elder 

Facsimile No.: (312) 862-2200 

Email: obrienm@kirkland.com and christopher.elder@kirkland.com 

To any other Stockholder: 
 To the
address set forth on the applicable schedule hereto or, if no address is set forth thereon, to the address on file with the Company for such Stockholder, 

or to such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party in
accordance herewith. 
 (g) Business Days. If any time period for giving notice or taking action hereunder expires on a day that is
not a Business Day, the time period shall automatically be extended to the Business Day immediately following such Saturday, Sunday or legal holiday. If any time period for giving notice or taking action hereunder begins after 5:00 p.m. (New York
City time), such time period shall automatically be deemed to begin on the Business Day immediately following such day. In the computation of periods of time from a specified date to a later specified date, the word “from” means “from
and including,” the words “to” and “until” mean “to but excluding” and the word “through” means “to and including.” 

(h) Governing Law. All issues and questions concerning the construction, validity, interpretation and enforcement of this Agreement and
the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any
other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. In furtherance of the foregoing, the internal law of the State of Delaware shall control the interpretation and construction of
this Agreement (and all schedules and exhibits hereto), even though under that jurisdiction’s choice of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily apply. 

(i) MUTUAL WAIVER OF JURY TRIAL. AS A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT
(AFTER HAVING THE OPPORTUNITY TO CONSULT WITH COUNSEL), EACH PARTY HERETO EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY. 

  
 18 

 (j) CONSENT TO JURISDICTION AND SERVICE OF PROCESS. EACH OF THE PARTIES HERETO HEREBY
IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE COURT OF CHANCERY OF THE STATE OF DELAWARE (OR, IF (AND ONLY IF) THE COURT OF CHANCERY OF THE STATE OF DELAWARE DECLINES TO ACCEPT OR DOES NOT HAVE JURISDICTION OVER A PARTICULAR MATTER, THE
SUPERIOR COURT OF THE STATE OF DELAWARE OR ANY FEDERAL COURT SITTING IN THE STATE OF DELAWARE) OVER ANY SUIT, ACTION OR OTHER PROCEEDING BROUGHT BY ANY PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT, AND EACH OF THE PARTIES HERETO HEREBY
IRREVOCABLY AGREES THAT ALL CLAIMS WITH RESPECT TO ANY SUCH SUIT, ACTION OR OTHER PROCEEDING SHALL BE HEARD AND DETERMINED IN SUCH COURTS. EACH OF THE PARTIES HERETO FURTHER AGREES THAT SERVICE OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT BY U.S.
REGISTERED MAIL TO SUCH PARTY’S RESPECTIVE ADDRESS SET FORTH IN SECTION 11(f) OR ON THE SCHEDULES HERETO SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING WITH RESPECT TO ANY MATTERS TO WHICH IT HAS SUBMITTED TO
JURISDICTION IN THIS SECTION. EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY OBJECTION TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR OTHER PROCEEDING BROUGHT BY ANY PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT IN THE
COURT OF CHANCERY OF THE STATE OF DELAWARE (OR, IF (AND ONLY IF) THE COURT OF CHANCERY OF THE STATE OF DELAWARE DECLINES TO ACCEPT OR DOES NOT HAVE JURISDICTION OVER A PARTICULAR MATTER, THE SUPERIOR COURT OF THE STATE OF DELAWARE OR ANY FEDERAL
COURT SITTING IN THE STATE OF DELAWARE) AND HEREBY AND THEREBY FURTHER IRREVOCABLY AND UNCONDITIONALLY WAIVES AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH SUIT, ACTION, OR OTHER PROCEEDING BROUGHT IN ANY SUCH COURT HAS
BEEN BROUGHT IN AN INCONVENIENT FORUM. 
 (k) Descriptive Headings; Interpretation. The descriptive headings of this Agreement
are inserted for convenience only and do not constitute a part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather than by limitation. 

(l) No Strict Construction. The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to
express their mutual intent, and no rule of strict construction shall be applied against any party. 
 (m) Counterparts. This
Agreement may be executed in multiple counterparts, any one of which need not contain the signatures of more than one party, but all such counterparts taken together shall constitute one and the same agreement. 

(n) Electronic Delivery. This Agreement, the agreements referred to herein and each other agreement or instrument entered into in
connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent executed and delivered by means of a photographic, photostatic, facsimile or similar reproduction of such signed writing using a
facsimile machine or electronic mail shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in
person. At the request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver them to all other parties. No party
hereto or to any such agreement or instrument shall raise the use of a facsimile machine or electronic mail to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a
facsimile machine or electronic mail as a defense to the formation or enforceability of a contract and each such party forever waives any such defense. 

  
 19 

 (o) Further Assurances. In connection with this Agreement and the transactions
contemplated hereby, each holder of Stockholder Shares shall execute and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to effectuate and perform the provisions of this Agreement
and the transactions contemplated hereby. 
 (p) No Inconsistent Agreements. The Company shall not hereafter enter into any agreement
with respect to Company Capital Stock which violates the rights granted to, or is inconsistent with the rights or obligations of, the holders of Stockholder Shares in this Agreement. 

(q) No Third Party Beneficiaries. This Agreement shall be binding on each party hereto solely for the benefit of each other party hereto
and nothing set forth in this Agreement, express or implied, shall be construed to confer, directly or indirectly, upon or give to any Person other than the parties hereto from time to time any benefits, rights or remedies under or by reason of, or
any rights to enforce or cause the parties hereto to enforce, any provisions of this Agreement; provided, however, that (i) the directors and Sponsor Directors are express intended third party beneficiaries of
Section 2(d), (ii) the Sponsor Directors are express intended third party beneficiaries of Section 9(a) and Section 9(c) (iii) the members of the Sponsor Group are
express intended third party beneficiaries of Section 9(c) and Section 10. 

*    *    *    *    * 

  
 20 

 IN WITNESS WHEREOF, the parties have executed this Stockholders Agreement as of the date
first written above. 
  

			
	AVEANNA HEALTHCARE HOLDINGS INC.
		
	By:	 	             

	Its:	 	
		
	[•]	 	

  
 21 

 SCHEDULE OF SPONSORS 

 

			
	 Name and Address
	  	 Common Stock

	 Bain Capital Fund XI, L.P.
 c/o Bain Capital
Partners, LLC
 200 Clarendon Avenue
 Boston, MA 02116
	  	[ ]
		
	 BCIP Associates IV (US), L.P.
 c/o Bain Capital
Partners, LLC
 200 Clarendon Avenue
 Boston, MA 02116
	  	[ ]
		
	 BCIP Associates IV-B (US), L.P.

c/o Bain Capital Partners, LLC
 200 Clarendon Avenue

Boston, MA 02116
	  	[ ]
		
	 BCIP T Associates IV (US), L.P
 c/o Bain Capital
Partners, LLC
 200 Clarendon Avenue
 Boston, MA 02116
	  	[ ]
		
	 BCIP T Associates IV-B (US), L.P.

c/o Bain Capital Partners, LLC
 200 Clarendon Avenue

Boston, MA 02116
	  	[ ]
		
	 Randolph Street Investment Partners, L.P. – 2016 DIF

300 N LaSalle
 Chicago, IL 60654
	  	[ ]
		
	 Squam Lake Investors XI, L.P.
 c/o
Bain & Company, Inc.
 131 Dartmouth Street
 Boston, MA
02116
	  	[ ]
		
	 Bain & Company, Inc.
 131 Dartmouth
Street
 Boston, MA 02116
	  	[ ]
		
	 Wayne DeVeydt
 9910 Cumberland Road

Fishers, IN 46037
	  	[ ]
		
	 PSA Healthcare Investment Holding LLC
 c/o J.H.
Whitney Capital Partners, LLC
 130 Main Street
 New Canaan, CT
06840
	  	[ ]

  
 22 

			
	 JHW Iliad Holdings LLC
 c/o J.H. Whitney Capital
Partners, LLC
 130 Main Street
 New Canaan, CT 06840
	  	[ ]
		
	 JHW Iliad Holdings II LLC
 c/o J.H. Whitney
Capital Partners, LLC
 130 Main Street
 New Canaan, CT
06840
	  	[ ]
		
	 PSA Iliad Holdings LLC
 c/o J.H. Whitney Capital
Partners, LLC
 130 Main Street
 New Canaan, CT 06840
	  	[ ]
		
	 J.H. Whitney VII, L.P.
 c/o J.H. Whitney Capital
Partners, LLC
 130 Main Street
 New Canaan, CT 06840
	  	[ ]

  
 23 

 SCHEDULE OF EXECUTIVES 

 

			
	 Name and Address
	  	 Number and Class of Stockholder Shares

	 [ ]
	  	 [ ]

  
 24 

 SCHEDULE OF OTHER INVESTORS 

 

			
	 Name and Address
	  	 Number and Class of Stockholder Shares

	 [ ]
	  	 [ ]

  
 25 

 EXHIBIT A 

JOINDER TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT 

The undersigned is executing and delivering this Joinder pursuant to the Amended and Restated Stockholders Agreement of Aveanna Healthcare
Holdings Inc. (the “Company”) dated [ ], 2021 (as the same may hereafter be amended, the “Stockholders Agreement”), among the Company and certain of the Company’s stockholders. 

By executing and delivering this Joinder to the Company, the undersigned hereby agrees to become a party to, to be bound by, and to comply
with the provisions of the Stockholders Agreement as a [Sponsor / Executive / Other Investor] owning [•] Stockholder Shares as of the Effective Date in the same manner as if the undersigned were an original signatory
to the Stockholders Agreement, and the undersigned’s shares of [•] shall be included as Stockholder Shares under the Stockholders Agreement. 

Accordingly, the undersigned has executed and delivered this Joinder as of [•]. 

 

			
	[ENTITY NAME][if applicable]
		
	By:	 	
                

	Name:	 	
	[Title:]	 	[if applicable]

  
 26EX-10.8

 Exhibit 10.8 

AMENDED AND RESTATED 

AVEANNA HEALTHCARE HOLDINGS INC. 2017 STOCK INCENTIVE PLAN 

ARTICLE I 
 ESTABLISHMENT
AND PURPOSE; ADMINISTRATION 
 1.1 Establishment. Aveanna Healthcare Holdings Inc., a Delaware corporation (the
“Company”), hereby establishes a stock incentive plan to be known as the “Aveanna Healthcare Holdings Inc. 2017 Stock Incentive Plan” (the “Plan”). The Plan became effective as of the date (the
“Effective Date”) of its adoption by the Company’s board of directors (the “Board”) and was amended and restated on April 19, 2021. 

1.2 Purpose. The Plan is intended to promote the long-term growth and profitability of the Company and its Subsidiaries by providing
those persons who are or will be involved in the Company’s and its Subsidiaries’ growth with an opportunity to acquire an ownership interest in the Company, thereby encouraging such persons to contribute to and participate in the success
of the Company and its Subsidiaries. Under the Plan, the Company may make Awards to such present and future officers, directors, employees, consultants and advisors of the Company or its Subsidiaries as may be selected in the sole discretion of the
Board (collectively, the “Participants”). 
 1.3 Administration. The Board shall have the power and authority to
prescribe, amend and rescind rules and procedures governing the administration of the Plan, including, but not limited to, the full power and authority: (a) to interpret the terms of the Plan, the terms of any Awards made under the Plan, and
the rules and procedures established by the Board governing any such Awards, (b) to determine the rights of any person under the Plan, or the meaning of requirements imposed by the terms of the Plan or any rule or procedure established by the
Board, (c) to select the Participants to receive Awards under the Plan, (d) to set the exercise price of any Awards granted under the Plan, (e) to establish performance and vesting standards, (f) to impose such limitations,
restrictions and conditions upon such Awards as it shall deem appropriate, (g) to adopt, amend, and rescind administrative guidelines and other rules and regulations relating to the Plan, (h) to correct any defect or omission or reconcile
any inconsistency in the Plan, (i) to adopt procedures regarding the exercise and settlement of Awards, including establishing “black out” or other periods during which Awards may not be exercised or settled, and (j) to make all
other determinations and take all other actions necessary or advisable for the implementation and administration of the Plan, subject to such limitations as may be imposed by the Code or other applicable law. Each action of the Board (including each
determination of the Board) shall be final, binding and conclusive on all Participants and all other Persons. The Board may, to the extent permissible by law, delegate any of its authority hereunder to any duly authorized committee of the Board or
any other persons as it deems appropriate. 

 ARTICLE II 

DEFINITIONS 
 As used in
the Plan, the following terms shall have the meanings set forth below: 
 “Affiliate” of any Person means any other Person
controlled by, controlling or under common control with such Person; provided that the Company and its Subsidiaries shall not be deemed to be Affiliates of any Stockholder (as defined in the Stockholders Agreement). As used in this
definition, “control” (including, with its correlative meanings, “controlling,” “controlled by” and “under common control with”) means possession, directly or indirectly, of power
to direct or cause the direction of management or policies (whether through ownership of securities, by contract or otherwise). With respect to any Person who is an individual, “Affiliates” also includes, without limitation, any
member of such individual’s Family Group (as defined in the Stockholders Agreement). 
 “Aggregate Spread” of any
Option as of any particular date means (a) the aggregate Fair Market Value of the securities for which such Option is exercisable, minus (b) the aggregate exercise price payable by the holder of such Option in order to acquire such
securities. 
 “Aggregate Spread Per Share” means (a) the Aggregate Spread of the applicable Option, divided by
(b) the total number of securities for which such Option is exercisable. 
 “Awards” means Options and Deferred RSUs.

 “Award Agreement” means a written agreement between the Company and a Participant setting forth the terms, conditions,
and limitations applicable to an Award; provided that, unless expressly set forth in an Award Agreement and approved by the Board, all Award Agreements shall be deemed to include all of the terms and conditions of the Plan. 

“Award Stock” means, for any Participant, any Common Stock issued to such Participant upon exercise or settlement of any
Award granted hereunder. For all purposes of the Plan, Award Stock will continue to be Award Stock in the hands of any holder (including any Permitted Transferee) except for the Company, the Sponsors and purchasers pursuant to a Public Sale, and
each such other holder of Award Stock will succeed to all rights and obligations attributable to such Participant as a holder of Award Stock hereunder. Award Stock will also include shares of the capital stock issued with respect to shares of Award
Stock by way of a merger, stock split, stock dividend or other recapitalization. 
 “Cause” means (a) in the case
where there is no employment, consulting or similar agreement in effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date (or where there is such an agreement but it does not define
“cause”), that such Participant has: (i) failed or refused to comply with a material directive from the Board or, if applicable, the board of directors of any Subsidiary or the Participant’s supervisor; (ii) received a
confirmed positive illegal drug test result; (iii) abused alcohol in a manner that impairs the Participant’s ability to perform the Participant’s duties; (iv) violated a material written policy of the Company or its Subsidiaries;
(v) engaged in misconduct that could be injurious to the business of the Company or any Affiliate; or (vi) committed a felony or any crime involving moral turpitude; or (b) in the case where there is an employment, consulting or
similar agreement in effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date that defines “cause,” “cause” as defined under such agreement. 

“Code” means the Internal Revenue Code of 1986, as it may be amended from time to time. 

  
 2 

 “Common Stock” means the Company’s Common Stock, par value $0.01 per
share, or, in the event that the outstanding shares of Common Stock are hereafter recapitalized, converted into or exchanged for different stock or securities of the Company or its Affiliates, such other stock or securities. 

“Company Group” means the Company and its Subsidiaries. 

“Confidential Information” means any and all data and information relating to the Company Group, its activities, business, or
clients that (a) is disclosed to a Participant or of which a Participant becomes aware as a consequence of his or her employment and/or service with the Company Group; (b) has value to the Company Group; and (c) is not generally known
outside of the Company Group. “Confidential Information” shall include, but is not limited to the following types of information regarding, related to, or concerning the Company Group: trade secrets (as defined by O.C.G.A. § 10-1-761); financial information and projections, strategic plans, business plans, organizational plans, markets, sales, pricing policies, operational methods, customer lists,
referral source lists, compensation or benefits paid to employees or other service providers; terms or conditions of employment; human resources information or business related information contained in the Company Group’s computer or other
systems. “Confidential Information” also includes (i) combinations of information or materials which individually may be generally known outside of the Company Group, but for which the nature, method, or procedure for combining
such information or materials is not generally known outside of the Company Group; and (ii) any and all data and information relating to or concerning a third party that otherwise meets the definition set forth above, that was provided or made
available to the Company Group by such third party, and that the Company Group has a duty or obligation to keep confidential. This definition shall not limit any definition of “confidential information” or any equivalent term under state
or federal law. “Confidential Information” shall not include information that has become generally available to the public by the act of one who has the right to disclose such information without violating any right or privilege of
the Company Group. 
 “Deferred RSUs” means the deferred restricted stock units granted pursuant to Article VI. 

“Development” means (a) any and all ideas, trade secrets, information (including Confidential Information, know-how, processes, inventions, technology, discoveries, original works of authorship, modifications, enhancements, improvements, derivative works, computer software (including source code, executable code,
algorithms, pseudocode, firmware, interfaces, data, databases, and documentation), processes, methods, formulas, designs, trademarks, service marks, and logos (whether or not patentable, copyrightable or able to be protected as a trade secret and
whether or not reduced to practice) that are conceived, developed, designed, made, authored, contributed to or reduced to practice by a Participant (either solely or jointly with others) together with all physical or tangible embodiments of any of
the foregoing, (b) all modifications, enhancements, improvements, and derivations of any of the foregoing, and (c) all claims and rights in and to all of the foregoing existing in any jurisdiction throughout the world, whether or not
registration is or has been secured for any intellectual property rights embodied therein, including any intellectual property registrations or applications, any renewals and extensions thereof, and in and to all works based upon, derived from, or
incorporating any of the foregoing, and in and to all income, royalties, damages, claims, and payments now or hereafter due or payable with respect thereto, and in and to all causes of action, either in law or in equity for past, present or future

  
 3 

 
infringement based on any of the foregoing, and in and to all rights corresponding to any of the foregoing throughout the world, and all the rights embraced therein, including the right to make,
use, sell, offer for sale, duplicate, reproduce, copy, distribute, import, export, display, license, adapt, and prepare derivative works from, or modifications, improvements or enhancements to, any of the foregoing. 

“Disability,” for any Participant, (a) in the case where there is no employment, consulting or similar agreement in
effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date (or where there is such an agreement but it does not define “disability”), means such Participant’s eligibility to receive
disability benefits under the Company’s or its Subsidiary’s long-term disability plan or the inability of such Participant, as determined by the Board, to perform the essential functions of the Participant’s regular duties and
responsibilities, with or without reasonable accommodation, due to a medically determinable physical or mental illness which has lasted (or can reasonably be expected to last) for a period of six (6) consecutive months; or (b) in the case
where there is an employment, consulting or similar agreement in effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date that defines “disability,” “disability” as defined
under such agreement. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any
successor statute thereto, and the rules and regulations promulgated thereunder. 
 “Fair Market Value,” or “FMV,” means:
(a) if the Common Stock is listed on any established stock exchange, national market system or quoted or traded on any automated quotation system, including, without limitation, the Nasdaq Global Select Market, the Nasdaq Global Market or the
Nasdaq Capital Market of The Nasdaq Stock Market, the closing sales price for a share of Common Stock (or the closing bid, if no sales were reported) as quoted on such exchange or system on that trading day, as reported in The Wall Street Journal or
such other source as the Board deems reliable; (b) if the Common Stock is not listed on an established stock exchange, national market system or automated quotation system, but the Common Stock is regularly quoted by a recognized securities
dealer, the mean of the high bid and low asked prices for such date, or if no high bids and low asks were reported on such date, the high bid and low asked prices for a share of Common Stock on the last preceding date such bids and asks were
reported, as reported in The Wall Street Journal or such other source as the Board deems reliable; and (c) in the absence of an established market for the Common Stock, the value determined in good faith by the Board.. 

“Initial Public Offering,” or “IPO,” means the initial underwritten Public Offering consummated by the
Company that results in the shares of the Common Stock that are sold in such Public Offering being listed on the NASDAQ Stock Market. 

“Material Contact” means, with respect to any Participant, contact between such Participant and a customer or referral source
of the Company Group (a) with whom or which such Participant has or had dealings on behalf of the Company Group; (b) whose dealings with the Company Group are or were coordinated or supervised by such Participant; (c) about whom such
Participant obtains Confidential Information in the ordinary course of business as a result of his or her employment and/or service with the Company Group; or (d) who receives products or services of the Company Group, the sale or provision of
which results or resulted in compensation, commissions, or earnings for such Participant within the two (2) years prior to such Participant’s Termination Date. 

  
 4 

 “Options” means options granted pursuant to Article IV. 

“Permitted Transferee” has the meaning set forth in the Stockholders Agreement. 

“Person” means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock
company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof. 

“Public Offering” means any sale of the Company’s Common Stock by the Company to the public pursuant to an offering
registered under the Securities Act. 
 “Restricted Lines of Business” means, with respect to any Participant, (a) in
the case where there is no employment, consulting or similar agreement in effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date (or where there is such an agreement but it does not define
“restricted lines of business”), all of the business lines that the Company Group was operating or actively considering as of the Participant’s Termination Date; or (b) in the case where there is an employment, consulting or
similar agreement in effect between the Company or a Subsidiary and the Participant as of the date of the conduct in question or as of the Participant’s Termination Date that defines “restricted lines of business”, “restricted
lines of business” as defined under such agreement. If the conduct in question occurs during the Participant’s employment with the Company Group and there is no employment, consulting or similar agreement in effect between the Company or a
Subsidiary and the Participant (or where there is such an agreement but it does not define “restricted lines of business”), “Restricted Lines of Business” shall mean all of the business lines that the Company Group was
operating or actively considering as of the date of the conduct in question. 
 “Restricted Period” means, with respect to
any Participant, (a) in the case where there is no employment, consulting or similar agreement in effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date (or where there is such an agreement
but it does not define “restricted period”), the period of such Participant’s employment and/or service with the Company and its Subsidiaries, plus the period commencing on the Participant’s Termination Date and expiring on the
later of (i) one (1) year after such Participant’s Termination Date, and (ii) the length of time, if any, during which such Participant receives (or is eligible to receive, where such Participant declines or otherwise takes action to
reject), in connection with such Participant’s termination, severance benefits or other similar payments (other than payments in respect of the repurchase of equity interests in the Company) from the Company or its Subsidiaries pursuant to an
agreement with such Participant, the severance policies of the Company or its Subsidiaries then in effect on the Participant’s Termination Date, at the election of the Company or any of its Subsidiaries or otherwise (or the length of
time, in terms of compensation, used to determine the amount of such Participant’s severance benefits in the event such severance benefits are payable in a lump sum or on a schedule different than such length of time); or (b) in the case
where there is an employment, consulting or similar agreement in effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date that defines “restricted period”, “restricted period”
as defined under such agreement. 

  
 5 

 “Restricted Territory” means, with respect to any Participant, (a) in
the case where there is no employment, consulting or similar agreement in effect between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date (or where there is such an agreement but it does not define
“restricted territory”), the area that is within the United States and within a one hundred (100)-mile radius of each location where the Company Group conducts business as of such Participant’s Termination Date (if the conduct occurs
after the Participant’s Termination Date) or the date of the conduct in question (if the conduct occurs during the employment or service period); or (b) in the case where there is an employment, consulting or similar agreement in effect
between the Company or a Subsidiary and the Participant as of the Participant’s Termination Date that defines “restricted territory”, “restricted territory” as defined under such agreement. 

“Sale of the Company” means any transaction or series of transactions pursuant to which any Independent Third Party or group
of Independent Third Parties in the aggregate acquires (a) Company Capital Stock or Capital Stock of the surviving entity in a merger involving the Company, in each case, entitled to vote (other than voting rights accruing only in the event of
a default, breach, event of noncompliance or other contingency) to elect directors or managers with a majority of the voting power of the Company’s or the surviving entity’s board of directors or managers (whether by merger, consolidation,
reorganization, combination, sale or transfer of Company Capital Stock) or (b) all or substantially all of the Company’s assets determined on a consolidated basis; provided that a Public Offering shall not constitute a Sale of the
Company. “Capital Stock,” “Company Capital Stock,” and “Independent Third Party” have the meanings ascribed to such terms in the Stockholder Agreement. 

“Securities Act” means the Securities Act of 1933, as amended from time to time, or any successor federal law then in force,
together with all rules and regulations promulgated thereunder. 
 “Sponsors” means the Bain Sponsors and the Whitney
Sponsors (as such terms are defined in the Stockholders Agreement). 
 “Stockholders Agreement” means the Amended and
Restated Stockholders Agreement, dated as of [    ], 2021, by and among the Company, the Sponsors and certain other stockholders of the Company, as the same may be amended from time to time. 

“Subsidiary” means any corporation, partnership, limited liability company or other entity in which the Company owns,
directly or indirectly, stock or other equity securities or interests possessing 50% or more of the total combined voting power of such entity. 

“Termination Date” means (a) if the Participant is an employee at the time of the grant of an Award hereunder, the date
of the Participant’s termination of employment with the Company and its Subsidiaries for any or no reason, and (b) if the Participant is a non-employee director or consultant at the time of the grant
of an Award hereunder, the Participant’s termination of service with the Company and its Subsidiaries for any or no reason, in each case, regardless of whether the termination date is selected by agreement with the Company or unilaterally by
the Company or any of its Subsidiaries (as applicable) and whether advance notice is or is not given to the Participant. No period of notice that is or ought to have been given under applicable law in respect of the termination of employment or
service will be taken into account in determining entitlement under the Plan. Furthermore, a Participant who goes on a leave of absence approved by the 

  
 6 

 
Company or one of its Subsidiaries or specifically authorized by applicable law shall not be deemed to have ceased the Participant’s employment or service with the Company and its
Subsidiaries during the period of such leave; provided that the time vesting of such Participant’s Options under Section 4.3(a) and the time vesting of such Participant’s RSUs granted under Article
VI shall be suspended during the period of such leave, except to the extent such suspension is prohibited by applicable law. 

“Transfer” means any direct or indirect sale, transfer, assignment, pledge, encumbrance or other disposition (whether with or
without consideration and whether voluntary, involuntary or by operation of law, including to the Company or any of its Subsidiaries) of any interest. 

“Work Product” means, for any Participant, Developments conceived, developed, designed, made, invented, authored, contributed
to or reduced to practice by such Participant while employed by, or providing services to, the Company or any of its Subsidiaries. 

ARTICLE III 
 AWARDS AND
ELIGIBILITY 
 3.1 Awards. Awards under the Plan shall be granted in the form of
non-qualified stock options as described in Article IV or restricted stock units as described in Article VI. For the avoidance of doubt, no Option shall be an incentive stock option within the
meaning of Section 422(a) of the Code or any successor provision. Each Award shall be evidenced by a written Award Agreement containing such restrictions, terms, and conditions, if any, as the Board may require; provided that, except as
otherwise expressly provided in an Award Agreement, if there is any conflict between any provision of the Plan and an Award Agreement, the provisions of the Plan shall govern. 

3.2 Maximum Shares Available. An aggregate of no more than 798,438.5679 shares of Common Stock shall be reserved for issuance
with respect to Options and 15,000.0000 shares of Common Stock shall be reserved for issuance with respect to Deferred RSUs. All Awards shall be subject to adjustment by the Board as follows. In the event of any reorganization, recapitalization,
stock split, stock dividend, combination of shares, merger, consolidation or similar change affecting the Common Stock, the Board shall make such changes in the number and type of equity securities covered by outstanding Awards and the terms thereof
as the Board determines are necessary to prevent dilution or enlargement of rights of the Participants under the Plan. Without limiting the generality of the foregoing, in the event of any such transaction, the Board shall have the power to make
such changes as it deems appropriate in the number and type of shares covered by outstanding Awards, the prices specified therein, and the securities or other property to be received upon exercise or settlement (which may include providing for cash
payment (or no consideration) in exchange for cancellation of outstanding Awards). If any Awards expire unexercised or unpaid or are canceled, terminated or forfeited in any manner without the issuance of Common Stock or payment thereunder, the
shares with respect to which such Awards were granted shall again be available under the Plan, subject to the foregoing maximum amounts. Shares of Common Stock to be issued upon exercise or settlement of Awards may be either authorized and unissued
shares, treasury shares or a combination thereof, as the Board shall determine. 

  
 7 

 3.3 Eligibility. The Compensation Committee of the Board (the “Committee”)
may, from time to time, select the individuals who shall be eligible to participate in the Plan and the Awards to be made to each such Participant. The Committee may consider any factors it deems relevant in selecting the Participants and in making
Awards to such Participants. The Committee’s determinations under the Plan (including determinations of which persons are to receive Awards and in what amount) need not be uniform and may be made by it selectively among persons who are eligible
to receive Awards under the Plan. 
 3.4 No Right to Continued Employment or Service. Nothing in the Plan or in any Award Agreement,
as applicable, shall confer on any Participant any right to continue in the employment of, or to continue to provide services to, the Company or its Subsidiaries or interfere in any way with the right of the Company or its Subsidiaries to terminate
such Participant’s employment or service at any time for any or no reason or to change any terms of such Participant’s employment or service (including the rate of compensation). 

3.5 Return of Prior Awards. The Committee shall have the right, at its discretion, to require the Participants to return to the Company
Awards previously granted to them under the Plan in exchange for new Awards; provided that, no Participant shall be required, without such Participant’s prior written consent, to return any Award if the new Award is to be made on terms
less favorable to such Participant than the Award to be returned. Subject to the provisions of the Plan, such new Awards shall be upon such terms and conditions as are specified by the Board at the time the new Awards are made. 

3.6 Securities Laws. The Plan has been instituted by the Company to provide certain compensatory incentives to the Participants and is
intended to qualify for an exemption from the registration requirements under (a) the Securities Act pursuant to Rule 701 promulgated under the Securities Act and (b) applicable state securities laws. 

ARTICLE IV 
 OPTIONS

 4.1 Options. The Board shall have the right and power to grant to any Participant, at any time prior to the termination of the
Plan, Options in such quantity, at such price, on such terms and subject to such conditions as are consistent with the Plan and established by the Board. Options granted under the Plan shall be in the form described in this Article IV, or in
such other form or forms as the Board may determine, and shall be subject to such additional terms and conditions and evidenced by Award Agreements, as shall be determined from time to time by the Board. 

4.2 Exercise Price. Options granted under the Plan at the time of the original adoption of the Plan had an exercise price equal to the
greater of (a) the per share cash consideration paid by the Sponsors for Class A Common Stock in the Company, par value $0.01 per share (the “Closing Price”), and (b) the grant date Fair Market Value of a share of
Common Stock; provided that Accelerator Options (as defined below) had an exercise price equal to two (2) times the Closing Price (and in no event less than the grant date Fair Market Value of a share of Common Stock). Subsequent grants
have an exercise price equal to or greater than the grant date Fair Market Value of a share of Common Stock; provided that Accelerator Options (as defined below) have an exercise price equal to two (2) times the grant date Fair Market
Value of a share of Common Stock. 

  
 8 

 4.3 Vesting of Options. Unless otherwise set forth in an Award Agreement, all Options
shall be subject to vesting in accordance with the provisions of this Section 4.3. In addition to the other requirements set forth in this Section 4.3, unless otherwise set forth in an Award
Agreement, Options shall vest only so long as a Participant remains employed by (in the case of a grant of Options to a Participant who is an employee of the Company or its Subsidiaries as of the grant date) or provides services to (in the case of a
grant of Options to a Participant who is not an employee of, but rather is a director or consultant of, the Company or its Subsidiaries as of the grant date) the Company or one of its Subsidiaries from the grant date through the applicable vesting
date. Options shall be exercisable only to the extent that they are vested. Unless otherwise set forth in an Award Agreement, (1) Awards of Options may be divided into up to three tranches; (2) each tranche shall be exercisable for the
number of shares of Common Stock set forth in the Award Agreement; and (3) the three possible tranches shall be referred to hereunder as: “Time-Vesting Options,” “Performance-Vesting Options,” and
“Accelerator Options”. 
 (a) Time-Vesting Options. 

(i) General. The Time-Vesting Options will be subject to time vesting only and will vest in equal twenty percent (20%) installments on
each of the first five (5) anniversaries of the grant date, such that all Time-Vesting Options will be vested as of the fifth (5th) anniversary of the grant date (the “Time-Vesting Schedule”). 

(ii) Death or Disability. Upon termination of a Participant’s employment due to death or Disability, an additional forty percent
(40%) of the Time-Vesting Options will vest; provided that no more than one hundred (100%) of the Time-Vesting Options will vest as a result of this additional vesting. 

(iii) Sale of the Company. Notwithstanding the foregoing Time-Vesting Schedule, all Time-Vesting Options will fully vest immediately
prior to the consummation of a Sale of the Company. For the avoidance of doubt, no accelerated vesting will occur pursuant to this Section 4.3(a)(iii) absent the consummation of such Sale of the
Company. 
 (iv) IPO. An IPO of the Company or any of its Subsidiaries or any successor to any of them will not result in any
accelerated vesting of the Time-Vesting Options, and all Time-Vesting Options will continue to vest according to the Time-Vesting Schedule. 

(b) Performance-Vesting Options. The Performance-Vesting Options shall be subject to performance vesting and will only be deemed fully
vested when they have vested in accordance with the terms hereof. 
 (i) General. The Performance-Vesting Options will vest based
upon achievement of the VWAP Price (as defined below) thresholds set forth below. For the avoidance of doubt, no more than one hundred percent (100%) of the Performance-Vesting Options will vest. 

(ii) VWAP Vesting. The Performance-Vesting Options will vest if the volume weighted average price per share of Common Stock, as
quoted on the NASDAQ Stock Market or other applicable exchange or system (the “VWAP Average Price”), meets or exceeds, during any consecutive ninety (90)-day period (each, a “VWAP
Period”) commencing on or after 

  
 9 

 
the nine (9)-month anniversary of the IPO, the following thresholds. For the avoidance of doubt, the first date on which the Performance-Vesting Options are eligible to vest under this
Section 4.3(b)(ii) is the twelve (12)-month anniversary of the IPO, and the VWAP Average Price will be calculated by dividing the aggregate sale price of all shares of Common Stock sold during the VWAP Period by the total number of shares of
Common Stock sold during the VWAP Period. A designated percentage of the Performance-Vesting Options will vest upon achievement of the designated VWAP Average Price thresholds for the applicable VWAP Period, as follows: (A) 2.0x
Performance-Vesting Options (50% of the Performance-Vesting Options): one hundred percent (100%) of the 2.0x Performance-Vesting Options will vest as of the last day of a VWAP Period, if the VWAP Average Price during such VWAP Period equals or
exceeds $[ ]; and (B) 2.5x-3.0x Performance-Vesting Options (50% of the Performance-Vesting Options): the 2.5x-3.0x Performance-Vesting Options will vest as of
the last day of a VWAP Period on a straight-line basis based upon the achievement of a VWAP Average Price during such VWAP Period between $[ ] and $[ ], with zero percent (0%) vesting if the VWAP Average Price is below $[ ] and one hundred percent
(100%) vesting if the VWAP Average Price equals or exceeds $[ ]. For the avoidance of doubt, no Performance-Vesting Options will vest under this Section 4.3(b)(ii) if the VWAP Average Price for an applicable VWAP Period is
less than $[ ]. 
 (iii) Determination of Vesting. The Board shall determine in its good faith discretion whether the relevant
thresholds have been satisfied. 
 (iv) IPO. For the avoidance of doubt, any Performance-Vesting Options that are unvested as of the
consummation of an IPO will continue to performance vest following an IPO in accordance with Section 4.3(b). 
 (c)
Accelerator Options. The Accelerator Options will be subject to time vesting and will vest according to the Time-Vesting Schedule, including with respect to the accelerated time vesting provisions applicable upon the consummation of a Sale of
the Company. 
 ARTICLE V 

OPTION EXPIRATION AND EXERCISE 

5.1 Expiration. 
 (a)
Expiration of Term. All Options granted under the Plan shall expire at the close of business in the time zone of the Company’s headquarters on the tenth (10th) anniversary of the date of grant to the Participant of such Options (with
respect to such Options, the “Term”), subject to earlier expiration as provided in this Article V. 
 (b)
Expiration on Termination. Except as otherwise set forth in an Award Agreement, the portion of such Participant’s Options that have not fully vested as of the Participant’s Termination Date shall automatically expire
at such time without consideration. 
 (c) Sale of the Company. Any Performance-Vesting Options that will not vest (or have not
vested) upon or prior to the consummation of a Sale of the Company shall terminate and be canceled immediately before such Sale of the Company. 

  
 10 

 5.2 Exercise on Termination. Except as otherwise set forth in an Award Agreement, the
portion of a Participant’s Options that have vested as of such Participant’s Termination Date shall expire upon, the earlier to occur of: (a) the end of their Term and (b) (i) ninety (90) days after the Termination Date, if a
Participant is terminated without Cause or if the Participant resigns for any or no reason (other than under circumstances where the Board determines that Cause exists), (ii) one (1) year after the Termination Date, if a Participant is
terminated due to death or due to Disability, (iii) immediately upon termination if a Participant is terminated for Cause or if a Participant resigns under circumstances where the Board determines that Cause exists, and (iv) immediately
upon a Participant’s breach of any of the provisions contained in Article XI or any other non-competition or other restrictive covenant benefiting the Company or its Subsidiaries. 

5.3 Procedure for Exercise. At any time after all or any portion of a Participant’s Options have fully vested and prior to their
expiration, a Participant may exercise all or any portion (but not less than 10%) of such Options by (a) delivering written notice of exercise to the Company specifically identifying the particular Options to be exercised (an “Exercise
Notice”), together with a written acknowledgment to each of the items set forth in Section 7.1 (including that such Participant has read and has been afforded an opportunity to ask questions of the management of
the Company or its Subsidiaries regarding all financial and other information provided to such Participant regarding the Company or its Subsidiaries), (b) paying the applicable exercise price for such Options in connection with this
Section 5.3 and the applicable Award Agreement and (c) delivering an executed joinder to the Stockholders Agreement in accordance with Article VIII below and such other representations and agreements (including
any lock-up agreement) as the Company may deem necessary or advisable in connection with the exercise of such Options. Unless otherwise provided in an Award Agreement, payment by the Participant in connection
with any exercise shall be (i) made by a check payable to the Company or a wire transfer of immediately available funds of the amount equal to the product of the exercise price multiplied by the number of shares of Award Stock to be acquired
(the “Exercise Price Payment”), and the amount of any additional federal and state income taxes or any income taxes or employee’s social security contributions arising in any jurisdiction outside the United States required to
be withheld (or accounted for to appropriate revenue authorities by the Participant’s employer) by reason of the exercise of the Options (the “Tax Payment,” which amount shall be calculated by the Company and provided to the
Participant promptly following delivery of an Exercise Notice, and which shall be subject to later adjustment by the Company (with a corresponding payment by or refund to the Participant) in the event that any such adjustment is required), and
(ii) due in full from the Participant at the same time as delivery of the Exercise Notice (with the portion representing taxes or contributions due within ten (10) business days of the date on which the Company informs the Participant in
writing of the amount of such items pursuant to the provisions of this Section 5.3). For United States federal income tax purposes, the Company intends to treat Options as exercised at the time the Company issues the
applicable Award Stock to the Participant. Notwithstanding anything to the contrary in the foregoing, each Participant shall be permitted to pay the Exercise Price Payment with respect to his or her Options by way of a cashless exercise, and the
Board may permit, in its sole discretion, for a Participant to pay the Tax Payment with respect to his or her Options by way of a cashless exercise. Such cashless exercise shall be effectuated by the Company withholding from delivery to the
Participant the number of shares of Common Stock that have an aggregate Fair Market Value, determined as of the date of exercise, equal to the Exercise Price Payment and/or the Tax Payment (as applicable). 

  
 11 

 ARTICLE VI 

DEFERRED RESTRICTED STOCK UNITS 

6.1 Deferred RSUs. The Board shall have the right and power to grant to any Participant, at any time prior to the termination of the
Plan, Deferred RSUs in such quantity, at such price, on such terms and subject to such conditions as are consistent with the Plan and established by the Board. Deferred RSUs granted under the Plan shall be in the form described in this Article VI,
or in such other form or forms as the Board may determine, and shall be subject to such additional terms and conditions and evidenced by Award Agreements, as shall be determined from time to time by the Board. 

6.2 Vesting. Except as otherwise set forth in the applicable Award Agreement, all of a Participant’s Deferred RSUs shall be fully
vested as of the grant date. 
 6.3 Settlement. Within sixty (60) days following the first to occur between (a) a Sale of
the Company (provided that such Sale of the Company also constitutes a “change in control event” under Section 409A of the Code and the regulations promulgated thereunder) and (b) the Participant’s Termination Date
(provided that such Termination Date also constitutes a “separation from service” under Section 409A of the Code and the regulations promulgated thereunder) (as applicable, the “Settlement Date”), the
Participant shall receive the number of shares of Common Stock that corresponds to the number of Deferred RSUs then-outstanding, provided that, prior to the end of such sixty (60)-day period, the
Participant has fulfilled all of the conditions to the settlement of such Deferred RSUs established by the Company (which conditions include (a) if the Participant is not already a party to the Stockholders Agreement as of the settlement of
such Deferred RSUs, the Participant delivering an executed joinder to the Stockholders Agreement in accordance with Article VIII below and (b) executing such other representations and agreements (including any lock-up agreement) as the Company may from time to time deem to be necessary or advisable in connection with the settlement of Deferred RSUs). If the Participant has not satisfied all of the conditions to settling
the Participant’s Deferred RSUs within sixty (60) days following the Settlement Date, Award Stock will not be issued to the Participant and such Deferred RSUs will be forfeited with no consideration due. Notwithstanding anything to the
contrary herein, if the applicable sixty (60)-day period referred to herein spans, or could reasonably be expected to span, two calendar years, then any settlement of such Deferred RSUs required to be made under this Section 6.3 shall be
made in the later calendar year. 
 ARTICLE VII 

GENERAL PROVISIONS 
 7.1
Representations on Exercise or Settlement. In connection with any exercise or settlement of any Award and the issuance of Award Stock thereunder (other than pursuant to an effective registration statement under the Securities Act), the
Participant shall, by the act of delivering the Exercise Notice or by the act of receiving Award Stock upon settlement of an Award (as applicable and without any further action on the part of the Participant), represent and warrant to the Company
that, as of the time of such exercise or settlement, the Participant: 
 (a) has such knowledge and experience in financial and business
matters so as to be capable of evaluating the merits and risks of the Participant’s investment in the Award Stock, and the Participant is able to bear the economic risk of the investment in the Award Stock for an indefinite period of time
because the Award Stock is subject to the transfer restrictions contained in the Stockholders Agreement and has not been registered under the Securities Act or the securities laws of any state or other jurisdiction or foreign nation and, therefore,
cannot be resold, pledged, assigned or otherwise disposed of, unless they are subsequently registered under the Securities Act and under the applicable securities laws of certain states or foreign nations or unless an exemption from such
registration is available; 

  
 12 

 (b) is or was an officer, director, employee, consultant or advisor of the Company or one of
its Subsidiaries and, in connection with such employment or service, has obtained adequate information regarding the Company in order to make informed decisions regarding the acquisition and holding of Award Stock; 

(c) has had an opportunity to ask questions and receive answers concerning the terms and conditions of the offering of the Award Stock to be
acquired by the Participant hereunder and has had full access and the opportunity to review such other information concerning the Company as the Participant may have requested in making the Participant’s decision to invest in the Award Stock
being issued hereunder; 
 (d) acknowledges that the Award Stock is subject to the restrictions described herein and in the Stockholders
Agreement, and the Participant has received and reviewed a copy of the Stockholders Agreement; 
 (e) acknowledges that any certificate
representing the Award Stock shall include such legend(s) as are set forth in the Stockholders Agreement; 
 (f) has relied on the advice of,
or has consulted with, only the Participant’s own legal, financial and tax advisors, and the determination of the Participant to acquire the Award Stock pursuant to the Plan has been made by the Participant independent of any statements or
opinions as to the advisability of such acquisition or as to the properties, business, prospects or condition (financial or otherwise) of the Company and its Subsidiaries which may have been made or given by any other Person or by any agent or
employee of such Person, and independent of the fact that any other Person has decided to become a stockholder of the Company; and 
 (g)
acknowledges that the Company will rely upon the accuracy and truth of the foregoing representations in this Section 7.1 and hereby consents to such reliance. 

In connection with any exercise or settlement of any Award (or any portion thereof), the Participant shall make such additional customary investment
representations as the Company may require and the Participant shall execute such documents necessary for the Company to perfect exemptions from registration under federal and state securities laws as the Company may reasonably request. 

  
 13 

 7.2 Non-Transferability. 

(a) All Awards are personal to a Participant and are not Transferable by such Participant, other than by will or pursuant to applicable laws of
descent and distribution; provided that no such Transfer by will or pursuant to applicable laws of descent and distribution shall be effective until the later of (i) twenty (20) days following the date that the Company receives written
notice of such Transfer and (ii) unless otherwise agreed by the Board, the Company’s receipt of a written certification from each transferee stating that such Person is a “citizen of the United States” in accordance with 49
U.S.C. §§ 40102(a)(15) and 41102. Only a Participant, or the Participant’s estate, personal representatives or heirs are entitled to exercise any Option. All Award Stock issued pursuant to the exercise or settlement of any Award shall
not be Transferable except as permitted pursuant to the terms of the Stockholders Agreement. Any attempted Transfer of Awards or Award Stock issued upon exercise or settlement thereof which is not specifically permitted under the Plan or the
Stockholders Agreement shall be null and void. 
 (b) No Participant shall make any Transfer prohibited by this
Section 7.2 either directly or indirectly. Any Transfer or attempted Transfer in violation of this Section 7.2 shall be null and void. 

(c) The Company shall issue, in the name of each Participant to whom Award Stock has been granted or sold, stock certificates representing the
total number of shares of Award Stock granted or sold to such Participant, as soon as reasonably practicable after such grant or sale and deliver copies thereof. 

7.3 Rights as a Stockholder. A Participant holding an Award shall have no rights as a stockholder with respect to any shares of Award
Stock issuable upon exercise or settlement thereof until such Participant has satisfied all conditions to such exercise or settlement, including having delivered a joinder to the Stockholders Agreement in accordance with Article VIII below.

 7.4 Sale of the Company. 

(a) Notwithstanding anything to the contrary contained herein, subject to Section 5.1(c), immediately prior to the
consummation of a Sale of the Company, the Board may (in its sole discretion), with respect to any or all of the Options that are outstanding and vested at such time, take any of the following actions (consistent with the requirements of
Section 409A of the Code) with respect to the Options: (i) provide for the assumption, substitution or continuation of such vested Options, (ii) if the Fair Market Value of the underlying Award Stock as of the consummation of the Sale
of the Company exceeds the exercise price associated with such vested Options, cash out all or any portion of such vested Options in exchange for the Aggregate Spread, and (iii) if the Fair Market Value of the underlying Award Stock as of the
consummation of the Sale of the Company is less than the exercise price associated with such vested Options, unilaterally terminate all or any portion of such vested Options for no consideration. All Options that are not assumed, substituted or
continued will be terminated upon the consummation of a Sale of the Company. 
 (b) Notwithstanding anything to the contrary contained
herein, immediately prior to the consummation of a Sale of the Company, the Board may (in its sole discretion), with respect to any or all of the RSUs that are outstanding and vested but not yet settled in accordance with
Section 6.3 at such time, take any of the following actions (consistent with the requirements of Section 409A of the Code) with respect to the RSUs: (i) issue the underlying Award Stock or (ii) cash out all
or any portion of such vested RSUs in exchange for the Fair Market Value of the underlying Award Stock as of the consummation of the Sale of the Company. 

  
 14 

 (c) Participants will (i) be required to execute any definitive transaction documents
in connection with any Sale of the Company at the request of the Company or its Subsidiaries or Affiliates, the Sponsors, or any of their collective successors and (ii) vote for (to the extent entitled to vote), at a stockholders meeting or by
written consent, and shall consent to, participate in and raise no objections against, the Sale of the Company and the process by which such Sale of the Company is arranged. 

ARTICLE VIII 
 JOINDERS

 Receipt of any Award shall constitute agreement by the Participant receiving such Award to be bound by all of the terms and
conditions of the Stockholders Agreement, including with respect to the Award Stock, or any other Company Capital Stock, issuable to or held by such Participant. In furtherance thereof, upon the receipt of any Award Stock, and without any further
required action of the Participant, the Company or any other Person, the Participant shall automatically become a party to the Stockholders Agreement as an Executive (and subject to the corresponding restrictions), and the Participant shall execute
a joinder to the Stockholders Agreement. All of the terms of the Stockholders Agreement are incorporated herein by reference. 
 ARTICLE
IX 
 RESERVED 

ARTICLE X 
 COMPLIANCE
WITH LAWS 
 Each Award, and the issuance of any Award Stock pursuant to an Award, shall be subject to the requirement that if at any
time the Board shall determine, in its discretion, that the listing, registration or qualification of the shares subject to such Award upon any securities exchange or under any state or federal securities or other law or regulation or the consent or
approval of any governmental regulatory body is necessary or desirable as a condition to or in connection with the granting of such Award or the issuance or purchase of shares thereunder, no such Award may be exercised or settled in Common Stock, in
whole or in part, unless such listing, registration, qualification, consent or approval (a “Required Listing”) shall have been effected or obtained. In connection with any Required Listing, the holder of the Award will supply the
Company with such certificates, representations and information as the Company shall request which are reasonably necessary or desirable in order for the Company to obtain such Required Listing, and shall otherwise cooperate with the Company in
obtaining such Required Listing. In the case of officers and other persons subject to Section 16(b) of the Exchange Act, the Board may at any time impose any limitations upon the exercise or settlement of an Award which, in the Board’s
discretion, are necessary or desirable in order to comply with Section 16(b) of the Exchange Act and the rules and regulations thereunder. If the Company, as part of an offering of securities or otherwise, finds it desirable because of federal
or state regulatory requirements to reduce the period during which any Awards may be exercised or settled, the Board may, in its discretion and without the consent of the holders of any such Awards, so reduce such period on not less than ten
(10) days’ written notice to the holders thereof. 

  
 15 

 ARTICLE XI 

RESTRICTIVE COVENANTS 
 The
Company and its Subsidiaries operate in a highly sensitive and competitive commercial environment. As part of the Participant’s employment and/or service with the Company and/or its Subsidiaries, the Participant will be exposed to highly
confidential and sensitive information regarding the Company’s and its Subsidiaries’ business operations, including corporate strategy, pricing and other market information, know-how, trade secrets,
and valuable customer, supplier, strategic partner, licensee, licensor, lessor, regulatory and employee relationships. It is critical that the Company take all necessary steps to safeguard its legitimate protectable interests in such information and
to prevent any of its competitors or any other persons from obtaining any such information. Therefore, as consideration for the Company’s agreement to award Awards to a Participant, each Participant agrees to be bound by all of the provisions
of this Article XI; provided that the provisions of Sections 11.2 through 11.6 shall not apply to a Participant who is serving the Company Group exclusively as a non-employee
director of the Company Group at the time of receipt of an Award. 
 11.1 Confidentiality. Each Participant agrees that he or she
shall not, directly or indirectly, use any Confidential Information on his or her own behalf or on behalf of any person or entity other than Company Group, or reveal, divulge, or disclose any Confidential Information to any person or entity not
expressly authorized by the Company to receive such Confidential Information. This obligation shall remain in effect for as long as the information or materials in question retain their status as Confidential Information. Each Participant further
agrees that he or she shall reasonably cooperate with the Company Group in maintaining the Confidential Information to the extent permitted by law. Anything herein to the contrary notwithstanding, a Participant shall not be restricted from
disclosing information that is required to be disclosed by law, court order, in a proceeding to enforce the terms of the Plan, or other valid and appropriate legal process; provided, however, that in the event such disclosure is required by law, the
Participant shall provide the Company with prompt notice of such requirement so that the Company may seek an appropriate protective order prior to any such required disclosure by the Participant. 

(a) Nothing in the Plan or any Award Agreement shall prohibit or restrict the Company, the Company’s Affiliates, the Participants or their
respective attorneys from: (i) making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to the Plan or any Award made hereunder, or as required by law or legal process,
including with respect to possible violations of law; (ii) participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency or legislative body, any self-regulatory
organization, and/or pursuant to the Sarbanes-Oxley Act; or (iii) accepting any U.S. Securities and Exchange Commission awards. In addition, nothing in the Plan or any Award Agreement prohibits or restricts the Company, the Company’s
Affiliates or the Participants from initiating communications with, or responding to any inquiry from, any regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation. 

  
 16 

 (b) Pursuant to 18 U.S.C. § 1833(b), a Participant will not be held criminally or
civilly liable under any Federal or State trade secret law for the disclosure of a trade secret of the Company or its Affiliates that (i) is made (A) in confidence to a Federal, State, or local government official, either directly or
indirectly, or to the Participant’s attorney and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document that is filed under seal in a lawsuit or other
proceeding. If a Participant files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Participant may disclose the trade secret to the Participant’s attorney and use the trade secret information in the
court proceeding, if the Participant files any document containing the trade secret under seal and does not disclose the trade secret except under court order. Nothing in the Plan or any Award Agreement is intended to conflict with 18 U.S.C. §
1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. 
 11.2 Assignment of
Inventions. Any copyrightable work falling within the definition of Work Product shall be deemed a
“work-made-for-hire” under the copyright laws of the United States (17 U.S.C. 101 et seq.), and ownership of all rights
therein shall vest in the Company or its Subsidiaries, as applicable, from the moment of fixation. In the event that any Work Product is deemed not to be a “work-made-for-hire,” or if other rights may at any time be embodied in any Work Product, the Participant hereby assigns and transfers, and agrees to assign and transfer to the Company and
its legal successors and assigns, the entire right, title, and interest in and to such Work Product. The Participant hereby waives, to the extent permitted by applicable law, all “moral rights” the Participant has in and to the Work
Product. The Participant will promptly disclose any Work Product as may be susceptible of such manner of communication to the Company and perform all actions reasonably requested by the Company (whether before or after the Participant’s
Termination Date) to establish and confirm such ownership (including, without limitation, the execution and delivery of assignments, affidavits, declarations, oaths, exhibits, consents, powers of attorney and other instruments and documentation) and
to provide reasonable assistance to the Company or any of its Subsidiaries in connection with the application and prosecution of any applications for any intellectual property rights or reissues thereof or in the prosecution or defense of
interferences relating to any Work Product. Should the Company be unable to secure the Participant’s signature on any document necessary to apply for, prosecute, obtain, or enforce any patent, copyright, or other right or protection relating to
any Work Product, whether due to the Participant’s mental or physical incapacity or any other cause, the Participant hereby irrevocably designates and appoints the Company and each of its duly authorized officers and agents as the
Participant’s agent and attorney in fact, to act for and in the Participant’s behalf and stead, to execute and file any such document, and to do all other lawfully permitted acts to further the prosecution, issuance, and enforcement of
patents, copyrights, or other rights or protections with the same force and effect as if executed and delivered by the Participant. 
 11.3
Notice of Statutory Exception. Notwithstanding anything to the contrary contained in the Plan, Work Product shall not include any invention developed entirely on the Participant’s own time without using any equipment, supplies,
facilities, or trade secrets of the Company or any of its Subsidiaries, unless such invention (a) relates at the time of conception or reduction to practice to the business of the Company or its Subsidiaries or its and actual or demonstrably
anticipated research or development of the Company or its Subsidiaries, or (b) results from any work performed by the Participant for Company or any of its Subsidiaries. 

  
 17 

 11.4 Non-Competition. During the Restricted
Period, a Participant will not, directly or indirectly, on his or her own behalf or on behalf of another, (a) carry on or engage in one or more of the Restricted Lines of Business within the Restricted Territory or (b) own, manage,
operate, join, control or participate in the ownership, management, operation or control, of any business, whether in corporate, proprietorship or partnership form or otherwise where such business is engaged in one or more of the Restricted Lines of
Business within the Restricted Territory. Notwithstanding the foregoing, this Section 11.4 shall not restrict a Participant from passively investing in or holding up to two percent (2%) of the equity securities of an entity
engaged in the Restricted Lines of Business, which securities are publicly traded. 
 11.5 Nonsolicitation of Employees and
Contractors. During the Restricted Period, a Participant will not, directly or indirectly, on his or her own behalf or on behalf of any other person or entity, solicit for employment or services, or encourage or attempt to persuade any employee
or contractor of any member of the Company Group to terminate or otherwise modify his or her employment or service with such member of the Company Group; provided, that the foregoing shall not limit the Participant’s right to participate
in job fairs or to place advertisements not directed solely at the employees or contractors of members of the Company Group. An employee or contractor of any member of the Company Group shall be deemed covered by this
Section 11.5 while such employee or contractor is employed or retained by such member of the Company Group and for a period of six (6) months after the termination of such employee’s or contractor’s
employment or service with such member of the Company Group. 
 11.6 Nonsolicitation of Customers and Referral Sources. During
the Restricted Period, a Participant will not, directly or indirectly, on his or her own behalf or on behalf of any other person or entity, (a) solicit any business related to the Restricted Lines of Business or (b) solicit any customer or
referral source of any member of the Company Group to terminate or modify to such member of the Company Group’s disadvantage such customer’s or referral source’s business relationship with such member of the Company Group. This
covenant is limited to customers and referral sources (i) that are located or otherwise conduct business in the Restricted Territory (as defined below) or (ii) with whom or which the Participant has had Material Contact on behalf of the
Company Group during his or her employment and/or service with the Company. As to “customers,” this covenant is limited to solicitations in which a Participant offers products or services that are competitive with those offered by any
member of the Company Group at the time of termination of employment or service. As to “referral sources,” this covenant is limited to solicitation for the purpose of obtaining referrals of the same type as referrals a member of the
Company Group would seek from the referral source at the time of termination of employment or service. 
 11.7 Non-Disparagement. A Participant shall not make or solicit or encourage others to make or solicit directly or indirectly any derogatory or negative statement or communication about the Company Group or its
Affiliates or any of their respective businesses, products, services or activities; provided that such restriction shall not prohibit truthful testimony compelled by valid legal process, required governmental testimony or filings, or
administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings). 

  
 18 

 11.8 Return of Materials. Each Participant agrees that he or she will not retain or
destroy (except as set forth below), and will immediately return to the Company Group on or prior to the Termination Date, or at any other time any member of the Company Group requests such return, any and all property of the Company Group that is
in his or her possession or subject to his or her control, including, but not limited to, keys, credit and identification cards, personal items or equipment, customer files and information, papers, drawings, notes, manuals, specifications, designs,
devices, code, email, documents, diskettes, CDs, tapes, keys, access cards, credit cards, identification cards, computers, mobile devices, other electronic media, all other files and documents relating to the Company Group and its business
(regardless of form, but specifically including all electronic files and data of the Company Group), together with all Confidential Information in tangible or electronic form belonging to the Company Group or that the Participant received from or
through his or her employment and/or service with the Company Group. A Participant will not make, distribute, or retain copies of any such information or property. To the extent that a Participant has electronic files or information in his or her
possession or control that belong to the Company Group or contain Confidential Information (specifically including but not limited to electronic files or information stored on personal computers, mobile devices, electronic media, or in cloud
storage), on or prior to the Termination Date, or at any other time any member of the Company Group requests, the Participant shall (a) provide the Company Group with an electronic copy of all of such files or information (in an electronic
format that readily accessible by the Company Group); and (b) after doing so, delete all such files and information, including all copies and derivatives thereof, from all computers not owned by the Company Group, mobile devices, electronic
media, cloud storage, or other media, devices, or equipment, such that such files and information are permanently deleted and irretrievable. Notwithstanding the foregoing, a Participant shall be permitted to retain a copy of mutually agreeable
presentations and other documents not containing Confidential Information that demonstrate the results the Participant achieved with the Company Group, such agreement not to be unreasonably withheld. 

11.9 Cooperation. Each Participant agrees that, for the Restricted Period and, if longer, during the pendency of any litigation or other
proceeding arising from events and circumstances occurring during the Participant’s employment and/or service with the Company Group, (a) the Participant shall not communicate with anyone (other than the Participant’s attorneys and
tax and/or financial advisors and except to the extent the Participant determines in good faith is necessary in the performance of the Participant’s duties) with respect to the facts or subject matter of any pending or potential litigation, or
regulatory or administrative proceeding involving the Company Group, other than any litigation or other proceeding in which the Participant is a party-in-opposition,
without giving prior notice to the Company or the Company’s counsel, and (b) in the event that any other party attempts to obtain information or documents from the Participant (other than in connection with any litigation or other
proceeding in which the Participant is a party-in-opposition) with respect to matters the Participant believes in good faith are related to such litigation or other
proceeding, the Participant shall promptly so notify the Company’s counsel. The Participant agrees to cooperate, in a reasonable and appropriate manner, with the Company Group and its attorneys, both during, and after the termination of, the
Participant’s employment and/or service, in connection with any litigation or other proceeding arising out of or relating to matters in which the Participant was involved prior to the Termination Date to the extent (i) the amount of time
the Participant is required to devote or expend is reasonable in respect of the Participant’s ability to otherwise conduct the Participant’s business and affairs and earn a livelihood reasonably satisfactory to the Participant; and
(ii) a member of the Company Group pays all Company-approved expenses the Participant incurs (including reasonable attorneys’ fees and costs) and 

  
 19 

 
provides satisfactory reimbursement, on a per-day basis, to the Participant for the Participant’s time devoted and expended, in each case, in
connection with such cooperation. Such reimbursement shall be at an hourly rate equivalent to the base salary the Participant was earning immediately prior to the Termination Date, divided by 2,080; provided that no additional compensation
will be payable during any period of time during which the Participant is receiving severance or other post-termination pay from any member of the Company Group. 

11.10 No Restriction on Earning a Living. Each Participant hereby acknowledges that the provisions of Article XI do not preclude
the Participant from earning a livelihood, nor do they unreasonably impose limitations on the Participant’s ability to earn a living. In addition, the Participant hereby acknowledges that the potential harm to the Company and/or its
Subsidiaries of non-enforcement of Article XI outweighs any harm to the Participant of enforcement (by injunction or otherwise) of Article XI against the Participant. If any portion of the
provisions of Article XI is found to be invalid or unenforceable by a court of competent jurisdiction because its duration, territory, definition of activities covered, or definition of information covered is considered to be unreasonable in
scope, the invalid or unenforceable term shall be narrowed, limited or redefined, or a new enforceable term provided, such that the intent of the Company and the Participant in agreeing to the provisions of Article XI will be preserved, and
the provision in question shall be enforceable, to the fullest extent permitted by applicable law. 
 11.11 Additional Acknowledgements;
Remedies. Each Participant acknowledges that the restrictions contained in this Article XI are reasonable and necessary to protect the legitimate interests of the Company and its Subsidiaries and that the Company would not have entered
into the Plan or any Award Agreement in the absence of such restrictions. The Participant also acknowledges that any breach by the Participant of this Article XI will cause continuing and irreparable injury to the Company and its Subsidiaries
for which monetary damages would not be an adequate remedy. The Participant shall not, in any action or proceeding to enforce any of the provisions of the Plan, assert the claim or defense that an adequate remedy at law exists or that this
Article XI is unreasonable or otherwise not enforceable in accordance with their terms. In the event that, notwithstanding the foregoing, the Participant challenges the reasonableness or enforceability of the restrictions contained in this
Article XI, the Participant shall pay the attorneys’ fees of the Company and/or its Subsidiaries, as applicable. In the event of such breach by the Participant, the Company or any of its Subsidiaries shall have the right to enforce the
provisions of this Article XI by seeking injunctive or other relief in any court, and the Plan shall not in any way limit remedies of law or in equity otherwise available to such entity. The periods of time set forth in this Article XI
shall not include, and shall be deemed extended by, any period during which the Participant is in breach of any such restriction, and, if litigation is pursued by the Company or any Subsidiary, any time required for litigation to enforce the
relevant covenant periods, provided that the Company or any of its Subsidiaries is successful on the merits in any such litigation. The “time required for litigation” is herein defined to mean the period of time from the earlier of
the Participant’s first breach of such covenants or service of process upon the Participant through the expiration of all appeals related to such litigation. 

11.12 Survival of Provisions. The obligations contained in this Article XI shall survive the termination of the
Participant’s employment and service with the Company and its Subsidiaries and shall be fully enforceable thereafter. 

  
 20 

 ARTICLE XII 

OTHER PROVISIONS 
 12.1
Indemnification. No member of the Board, nor any person to whom administrative or ministerial duties have been delegated, shall be personally liable for any action, interpretation or determination made with respect to the Plan or Awards made
thereunder (except, if applicable, in his or her capacity as a Participant hereunder), and each member of the Board shall be fully indemnified and held harmless by the Company with respect to any liability such person may incur with respect to any
such action, interpretation or determination, to the extent permitted by applicable law and to the extent provided in the Company’s Certificate of Incorporation and Bylaws, as amended from time to time, or under any agreement between any such
Board member and the Company. 
 12.2 Termination and Amendment. The Board at any time may suspend or terminate the Plan and make such
additions or amendments as it deems advisable under the Plan and any Award Agreement; provided that, the Board may not change any of the terms of the Plan or an Award Agreement in a manner adverse to a Participant without the prior written
approval of such Participant; provided, further, that to the extent the Board amends the Plan or any Award Agreement in a manner adverse to a Participant without such Participant’s consent, such Participant and the Company
shall continue to be bound and governed by the terms of the Plan and such Award Agreement as in effect prior to such amendment. 
 12.3
Taxes. Subject to Section 5.3, the Company shall have the right to require the Participants or their beneficiaries or legal representatives to remit to the Company an amount sufficient to satisfy the
Participant’s minimum federal, state, local and foreign withholding tax requirements, as applicable, or to deduct from all payments under the Plan amounts sufficient to satisfy such minimum withholding tax requirements. Whenever payments under
the Plan are to be made to a Participant in cash, such payments shall be net of any amounts sufficient to satisfy all federal, state, local and foreign withholding tax requirements, as applicable. 

12.4 Data Collection. By participating in the Plan or accepting any rights granted under it, each Participant consents to the collection
and processing of personal data relating to the Participant so that the Company and its Affiliates can fulfill their obligations and exercise their rights under the Plan and generally administer and manage the Plan. This data will include, but may
not be limited to, data about participation in the Plan and shares offered or received, purchased or sold under the Plan from time to time and other appropriate financial and other data (such as the date on which the Awards were granted) about the
Participant and the Participant’s participation in the Plan. 
 12.5 Notices. Notices required or permitted to be made under the
Plan shall be in writing and shall be deemed given, delivered and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile prior to 5:00 p.m. (New York time) on a business day,
(b) the business day after the date of transmission, if such notice or communication is delivered via facsimile later than 5:00 p.m. (New York time) on any business day and earlier than 11:59 p.m. (New York time) on the day preceding the next
business day, (c) one (1) business day after when sent, if sent by nationally recognized overnight courier service (charges prepaid), or (d) upon actual receipt by the person to whom such notice is required to be given. All notices shall
be addressed, if to (i) a Participant, to such Participant’s address as set forth in the books and records of the Company and its Subsidiaries, and (ii) the Company or the Board, to the principal office of the Company as set forth in
the Stockholders Agreement, clearly marked “Attention: Board of Directors”. 

  
 21 

 12.6 Severability. In the event that any court of competent jurisdiction determines
that any provision of the Plan is, under applicable law, invalid or unenforceable in any respect, such provision shall be construed by modifying or limiting it so as to be valid and enforceable to the maximum extent permitted under applicable law.
The provisions of the Plan are severable, and in the event any provision hereof should be held invalid or unenforceable in any respect, it shall not invalidate, render unenforceable or otherwise affect any other provision of the Plan. 

12.7 Prior Agreements. Except as expressly stated otherwise, no provision of any employment, severance, incentive award, or other
similar agreement entered into by a Participant, on the one hand, and any Subsidiary of the Company, on the other hand, prior to the Effective Date shall modify or have any effect in any manner on any provision of the Plan or any term or condition
of any Award Agreement to which such Participant is a party. Without limiting the generality of the foregoing, any provision in any such agreement that purports to apply in any manner to options, stock, equity-based awards or the like shall not
apply to or have any effect on any Awards under the Plan. 
 12.8 Governing Law and Forum; Waiver of Jury Trial. The Plan shall be
governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule that would cause the application of the laws of any other jurisdiction. Each
Participant who accepts an Award thereby (a) agrees that any suit, action or proceeding brought by or against such Participant in connection with the Plan shall be brought solely in the Court of Chancery of the State of Delaware;
(b) consents to the jurisdiction and venue of such court; (c) submits to and accepts the exclusive jurisdiction of such court for the purpose of any such suit, legal action, or proceeding; (d) agrees to accept service of process by
the Company or any of its agents in connection with any such proceeding; (e) irrevocably waives any objection which such Participant may now or hereafter have to the laying of venue or any such suit, legal action or proceeding in such court;
and (f) further waives any claim that any suit, legal action or proceeding brought in such court has been brought in an inconvenient forum. EACH PARTICIPANT WHO ACCEPTS AN AWARD IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR
PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THE PLAN OR ANY AWARD OR THE MATTERS OTHERWISE CONTEMPLATED HEREBY. 
 12.9
Construction. The words “include,” “includes” or “including” shall be deemed to be followed by the words “without limitation.” Where specific language is used to clarify by example a general statement
contained herein (such as by using the words “such as”), such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates. Whenever required by the context,
any pronoun used in the Plan shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa. 

  
 22 

 12.10 Section 409A Compliance. It is the intention of the Company
and the Board that the Plan not be subject to the provisions of Section 409A of the Code, as in effect as of the Effective Date or as subsequently modified, or, to the extent subject to such provisions, to comply in all material respects with
such provisions. In the event that Section 409A of the Code would impose a tax, penalty, liability or other detriment on any Participant with respect to any Award under the Plan, then the Board shall consider in good faith modifications or
amendments to the Plan or any Award Agreement intended to eliminate or mitigate such detriment; provided that, in no event shall the Board be required to modify or amend the Plan in a manner adverse to the Company or the Sponsors;
provided, further, that, in no event shall the Company or its Affiliates be responsible for any taxes or penalties incurred by a Participant in connection with any amounts or benefits received pursuant to the Plan or any Award
Agreement. 
 *    *    *    *    * 

  
 23

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00326-of-00352.parquet"}]]